Phosphorescent material
Improved heteroleptic Ir(III) complexes with twisted aryl substituents address efficiency and stability issues in OLEDs, offering lower evaporation temperatures and enhanced performance in white OLEDs through advanced synthesis methods.
Patent Information
- Application Number
- JP2024117625
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2009-07-29
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing OLED technologies face challenges in achieving high efficiency and stability, particularly in full-color displays, due to limitations in phosphorescent materials and impractical synthetic methods for heteroleptic iridium complexes, leading to mixed product yields and high evaporation temperatures.
Development of heteroleptic Ir(III) complexes with extended conjugation and twisted aryl substituents, synthesized through improved methods using alkyl-substituted phenylpyridine ligands, which reduce ligand disorder and lower evaporation temperatures, enhancing device stability and efficiency.
The new phosphorescent materials provide improved device stability and manufacturing processes, with reduced evaporation temperatures and enhanced efficiency, particularly in white OLEDs, by utilizing heteroleptic Ir(III) complexes with specific ligand configurations.
Smart Images

Figure 2024159757000001_ABST
Abstract
Description
[Technical field]
[0001] This application claims priority to U.S. Provisional Application No. 60 / 940310, filed May 25, 2007, U.S. Provisional Application No. 61 / 093967, filed September 3, 2008, U.S. Provisional Application No. 61 / 140459, filed December 23, 2008, U.S. Provisional Application No. 61 / 229088, filed July 28, 2009, and PCT / US09 / 52045, filed July 29, 2009, the disclosures of which are expressly incorporated herein by reference in their entireties.
[0002] The claimed invention was made by, for, and / or in connection with one or more of the following parties under joint university corporation research agreements: The Regents of the University of Michigan, Princeton University, the University of Southern California, and Universal Display Corporation, which agreements were in effect at or before the time the claimed invention was made, and which invention was made as a result of activities within the scope of those agreements.
[0003] The present invention relates to organic materials that are advantageous for use in organic light emitting devices. More particularly, the present invention relates to organic materials for such devices as well as methods of making the novel organic materials. [Background technology]
[0004] Optoelectronic devices using organic materials are becoming increasingly desirable for several reasons. Many of the materials used to make such devices are relatively inexpensive, so organic optoelectronic devices have the potential for cost advantages over inorganic devices. Furthermore, the inherent properties of organic materials, such as their flexibility, make them well suited for certain applications, such as processing on flexible substrates. Examples of organic optoelectronic devices include organic light-emitting devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, organic materials can have performance advantages over conventional materials. For example, the wavelengths at which an organic light-emitting layer can emit light can usually be easily tuned with appropriate dopants.
[0005] OLEDs use organic thin films that emit light when a voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and structures are described in U.S. Patent Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entireties.
[0006] One application of phosphorescent molecules is in full color displays. Industry standards for such displays call for pixels adapted to emit specific colors, referred to as "saturated" colors. In particular, these standards call for saturated red, green and blue pixels. Color is measured using CIE coordinates, which are well known in the art.
[0007] One example of a green emissive molecule is tris(2-phenylpyridine)iridium, represented by Ir(ppy), which has the following structure: [ka] has.
[0008] In the diagrams above and hereinafter, the coordinate bond from nitrogen to the metal (here Ir) is shown as a straight line.
[0009] The term "organic" as used herein includes polymeric materials as well as small molecule organic materials used to fabricate organic optoelectronic devices. "Small molecule" refers to any organic material that is not a polymer, although "small molecules" may in fact be quite large. Small molecules may contain repeating units in some cases. For example, the use of long chain alkyl groups as substituents does not remove the molecule from the "small molecule" category. Small molecules may also be incorporated into polymers, for example, as pendant groups on a polymer backbone or as part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of the dendrimer may be a fluorescent or phosphorescent small molecule emitter. Dendrimers may be "small molecules," and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.
[0010] As used herein, "top" means furthest from the substrate and "bottom" means closest to the substrate. When a first layer is described as being "disposed over" a second layer, the first layer is disposed at a position furthest from the substrate. There may be other layers between the first and second layers, unless it is specified that the first layer is "in contact with" the second layer. For example, a cathode may be described as being "disposed over" an anode, even if various organic layers are present between them.
[0011] As used herein, "solution processable" means capable of being dissolved, dispersed or transported in a liquid medium, whether in solution or suspension, and / or precipitated therefrom.
[0012] A ligand can be referred to as "photoactive" if it is believed that the ligand directly contributes to the photoactive properties of the emissive material. A ligand can be referred to as "ancillary" if the ligand does not contribute to the photoactive properties of the emissive material, but the ancillary ligand can modify the properties of the photoactive ligand.
[0013] As used herein and generally understood by those skilled in the art, a first "highest occupied molecular orbital" (HOMO) or "lowest unoccupied molecular orbital" (LUMO) energy level is said to be "greater" or "higher" than a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IPs) are measured as negative energies relative to the vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (a less negative value of IP). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (a less negative value of EA). On a conventional energy level diagram with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A "higher" HOMO or LUMO energy level appears closer to the top of such a diagram than a "lower" HOMO or LUMO energy level.
[0014] As used herein and generally understood by those skilled in the art, a first work function is said to be "greater" or "higher" than a second work function if the first work function has a higher absolute value. Since work functions are usually measured as negative numbers relative to the vacuum level, this means that a "higher" work function has a more negative value. On a conventional energy level diagram, with the vacuum level at the top, a "higher" work function is represented as being further down from the vacuum level. Thus, the definition of the HOMO and LUMO energy levels follows a different convention than work functions.
[0015] Further details regarding OLEDs and the above definitions can be found in US Pat. No. 7,279,704, which is incorporated herein by reference in its entirety. [Prior art documents] [Patent documents]
[0016] [Patent Document 1] U.S. Patent No. 5,844,363 [Patent Document 2] U.S. Patent No. 6,303,238 [Patent Document 3] U.S. Patent No. 5,707,745 [Patent Document 4] U.S. Patent No. 7,279,704 [Patent Document 5] US Patent Application Publication No. 2003 / 0230980 [Patent Document 6] U.S. Patent No. 5,703,436 [Patent Document 7] U.S. Patent No. 4,769,292 [Patent Document 8] U.S. Patent No. 6,097,147 [Patent Document 9] US Patent Application Publication No. 2004 / 0174116 [Patent Document 10] U.S. Patent No. 5,247,190 [Patent Document 11] U.S. Patent No. 6,091,195 [Patent Document 12] U.S. Patent No. 5,834,893 [Patent Document 13] U.S. Patent No. 6,013,982 [Patent Document 14] U.S. Patent No. 6,087,196 [Patent Document 15] U.S. Patent No. 6,337,102 [Patent Document 16] U.S. Patent Application Serial No. 10 / 233470 [Patent Document 17] U.S. Patent No. 6,294,398 [Patent Document 18] U.S. Patent No. 6,468,819 [Patent Document 19] European Patent No. 1504015B1 [Patent Document 20] U.S. Patent No. 7,125,998 [Patent Document 21] U.S. Patent Application Serial No. 12 / 044848 [Patent Document 22] US Patent Application Publication No. 20060134459A1 [Patent Document 23] US Patent Application Publication No. 2007 / 0003789 [Patent Document 24] US Patent Application Publication No. 2009 / 0124805 [Patent Document 25] U.S. Patent No. 5,061,569 [Patent Document 26] European Patent No. 650955 [Patent Document 27] U.S. Patent Application Publication No. 20060202194 [Patent Document 28] WO2005014551 [Patent Document 29] US Patent Application Publication No. 2003175553 [Patent Document 30] WO2001039234 [Patent Document 31] U.S. Patent Application Publication No. 20060280965 [Patent Document 32] WO2004093207 [Patent Document 33] WO05089025 [Patent Document 34] WO06132173 [Patent Document 35] Japanese Patent Application No. 200511610 [Patent Document 36] Japanese Patent Application No. 2007254297 [Patent Document 37] WO07063796 [Patent Document 38] WO07063754 [Patent Document 39] WO04107822 [Patent Document 40] WO05030900 [Patent Document 41] U.S. Patent Application Publication No. 20070190359 [Patent Document 42] WO2006114966 [Patent Document 43] U.S. Patent No. 06835469 [Patent Document 44] U.S. Patent No. 07087321 [Patent Document 45] WO2003040257 [Patent Document 46] US Patent Application Publication No. 2002034656 [Patent Document 47] U.S. Patent No. 06687266 [Patent Document 48] U.S. Patent Application Publication No. 2006008670 [Patent Document 49] Japanese Patent Application No. 2007123392 [Patent Document 50] WO2002002714 [Patent Document 51] WO2006009024 [Patent Document 52] US Patent Application Publication No. 2006251923 [Patent Document 53] WO2006056418 [Patent Document 54] US Patent Application Publication No. 2005260441 [Patent Document 55] US Patent Application Publication No. 2002134984 [Patent Document 56] WO05123873 [Patent Document 57] WO07004380 [Patent Document 58] WO06082742 [Patent Document 59] US Patent Application Publication No. 2005260449 [Patent Document 60] WO06098120 [Patent Document 61] WO06103874 [Patent Document 62] U.S. Patent Application Publication No. 20050025993 [Patent Document 63] WO03060956
Non-licensed documents
[0017]
Non-patent document 1
Non-patent document 2
Non-patent document 3
Non-patent document 4
Non-patent document 5
Non-patent document 6
Non-patent document 7
Non-patent document 8
Non-patent document 9
Non-patent document 10
Non-patent document 11
Non-licensed Document 12
Non-licensed Document 13
Non-licensed Document 14
Non-licensed Document 15
Non-licensed Document 16
Non-licensed Document 17
Non-licensed Document 18
Non-licensed Document 19
Non-licensed Document 20
Non-licensed Document 21
Non-licensed Document 22
Non-licensed Document 23
Non-licensed Document 24
Non-licensed Document 25
Non-licensed Document 26
Non-licensed Document 27
Non-licensed Document 28
Non-licensed Document 29
Non-licensed Document 30
Non-licensed Document 31
Non-licensed Document 32
Non-licensed Document 33
Non-licensed Document 34
Non-licensed Document 35
Non-licensed Document 36
Non-licensed Document 37
Non-licensed Document 38
Non-licensed Document 39
Non-licensed Document 40
Non-licensed Document 41
Non-licensed Document 42
[0018] A method is provided for making heteroleptic Ir(III) complexes with extended conjugation, the method comprising: [ka] of [ka] React with [ka] The method includes the step of forming a fluorocarbon derivative comprising the steps of: S is a neutral ligand; X is a counter ion; and S is preferably selected from the group consisting of triflate, tosylate, trifluoroacetate, tetrafluoroborate, and hexafluorophosphate. A and B are each independently a 5- or 6-membered aromatic or heteroaromatic ring, and AB is ... 2 C and D each independently represent a 5- or 6-membered aromatic or heteroaromatic ring, and CD represents a bond between the nitrogen ring atom on ring C and the sp 2 R represents a bond pair of aromatic or heteroaromatic rings coordinated to iridium through a hybridized carbon atom. A , R B , R C and R D are each independently selected from the group consisting of unsubstituted, alkyl, heteroalkyl, aryl, or heteroaryl groups. A , R B , R C and R D Each of R represents one or more substituents. A , R B , R C and R D is selected from the group consisting of benzene, pyrimidine, pyridine, thiophene, thianaphthene, fluorine, carbazole and dibenzothiophene. R is an alkyl, heteroalkyl or perfluoroalkyl group, where two R are optionally joined to form a ring.
[0019] Further provided is a phosphorescent material, which is a heteroleptic complex having extended conjugation on the heterocycle. The material can be advantageously used in organic light-emitting devices. In particular, the material is useful as an emissive dopant in such devices. The material comprises: [ka] is selected from the group consisting of:
[0020] In one embodiment, compound 1 is preferred. In another embodiment, compound 2 is preferred.
[0021] Further provided is an organic light emitting device. The device has an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound selected from compounds 1-6. The organic layer can further comprise a host. Preferably, the host comprises a triphenylene group. More preferably, the host comprises triphenylene further substituted with terphenyl. Most preferably, the host is H1.
[0022] A consumer product is also provided, which includes a device having an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer further comprising a compound selected from Compounds 1-6.
[0023] Provided are heteroleptic iridium compounds that can be advantageously used in organic light emitting devices. The heteroleptic compounds include [ka] is selected from the group consisting of:
[0024] In one embodiment, compound 8 is preferred. In another embodiment, compound 9 is preferred. In yet another embodiment, compound 10 is preferred. In another embodiment, compound 11 is preferred. In yet another embodiment, compound 12 is preferred. In another embodiment, compound 13 is preferred. In yet another embodiment, compound 14 is preferred.
[0025] Further provided is an organic light-emitting device. The device has an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound selected from compounds 8-14. The organic layer can further comprise a host having a triphenylene group further substituted with an aryl or heteroaryl. Preferably, the host comprises a triphenylene group further substituted with a terphenyl or dibenzothiophene. More preferably, the host is H1 or H2.
[0026] A consumer product is also provided, which includes a device having an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer further comprising a compound selected from Compounds 8-14.
[0027] Additionally, a method is provided for making heteroleptic compounds without significant ligand scrambling, the method comprising: [ka] of, [ka] React with [ka] S is a neutral ligand. X is a counterion. Preferably, X is selected from the group consisting of triflate, tosylate, trifluoroborate and hexafluorophosphate. A and B are each independently a 5- or 6-membered aromatic or heteroaromatic ring, and AB is a nitrogen atom on ring A and a sp group on ring B. 2 C and D each independently represent a 5- or 6-membered aromatic or heteroaromatic ring, and CD represents a bond between the nitrogen ring atom on ring C and the sp 2 R represents a bond pair of aromatic or heteroaromatic rings coordinated to iridium through a hybridized carbon atom. A , R B , R C and R D are each independently selected from the group consisting of unsubstituted, alkyl, heteroalkyl, aryl, or heteroaryl groups; R A , R B , R C and R D Each of R represents one or more substituents. A , R B , RC and R D is selected from the group consisting of benzene, pyrimidine, pyridine, thiophene, thianaphthene, fluorine, carbazole and dibenzothiophene. Z is not H. Preferably, R Z is methyl.
[0028] Formula Ir(L A-B )2(L C-D The present invention provides a heteroleptic compound having the formula: A-B teeth, [ka] It is. C-D teeth, [ka] R1, R2, R3, R4 and R5 are each independently selected from the group consisting of hydrogen and alkyl, and each of R1, R2, R3, R4 and R5 may represent mono-, di-, tri-, tetra- or penta-substitution. Preferably, R1, R2, R3, R4 and R5 are each independently hydrogen and methyl. More preferably, L C-D teeth, [ka] is selected from the group consisting of:
[0029] Novel phosphorescent organic materials are provided. The organic materials are compounds that include at least one ligand having an alkyl and an aryl substituent, where the aryl substituent is twisted out of plane from the normal unsaturated phenyl-phenyl (i.e., twisted aryl, as used herein). The compounds can be advantageously used in organic light-emitting devices. In particular, the compounds are useful as light-emitting dopants in such devices.
[0030] The following structure: [ka] The present invention provides a compound comprising a ligand L having the formula:
[0031] B and C are each independently a 5- or 6-membered carbocyclic or heterocyclic ring. AB is a nitrogen atom on ring A and a sp 1 on ring B. 2 represents a bond pair of carbocyclic or heterocyclic rings coordinated with the metal M through a hybridized carbon atom. AC represents a bond pair of carbocyclic or heterocyclic rings. R a , R b and R C can represent mono-, di-, tri- or tetra-substitutions. a , R b and R C are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl and heteroaryl. X1, X2, X3, X4, X5, X6, X7, X8 and X9 are independently selected from carbon and nitrogen. Preferably, A is pyridine. R1 and R2 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl and heteroaryl. R1, R2 and the R adjacent to ring C are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl and heteroaryl. a At least one of the substituents is not hydrogen. Preferably, R, R, and R adjacent to C are a Only one of the substituents is not hydrogen. Preferably, R, R, and R adjacent to C are a Only one of the substituents is alkyl. More preferably, R, R, and R adjacent to C are a Only one of the substituents is ethyl. Most preferably, R, R and R adjacent to C are a Only one of the substituents is methyl. The ligand L is coordinated with a metal M having an atomic number greater than 40. Preferably, the metal M is Ir.
[0032] An example of the compound is a compound having the structure: [ka] may include.
[0033] m is the oxidation state of the metal M. Preferably, the metal M is Ir. Preferably, A is pyridine. n is at least 1. L' is a monoanionic bidentate ligand. Preferably, R1, R2, and R adjacent to C are a Only one of the substituents is not hydrogen. Preferably, R, R, and R adjacent to C are a Only one of the substituents is alkyl. More preferably, R, R, and R adjacent to C are a Only one of the substituents is ethyl. Most preferably, R, R and R adjacent to C are a Only one of the substituents is methyl.
[0034] Specific examples of compounds having formula II are provided. They include Compound 15 to Compound 20. R is not hydrogen. Preferably, R is alkyl.
[0035] Specific examples of compounds having formula II are provided below, including compounds 21 to 37. In one embodiment, compounds 21, 22, 25, 29, 30, 31, and 34 are preferred compounds.
[0036] In one aspect, [ka] At least one of R1, R2, R3, and R4 is not hydrogen. R5 is selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl. Preferably, A is pyridine. In one embodiment, R1 and R2 are hydrogen and one of R3 and R4 is alkyl. Exemplary compounds include compounds 21-24, 29-34, 36, and 37. In another embodiment, one of R1 and R2 is alkyl and R3 and R4 are hydrogen. Exemplary compounds include compounds 25-28, and 35.
[0037] In another aspect, the compound is [ka] is selected from the group consisting of:
[0038] Compounds having formula II include homoleptic and heteroleptic compounds. Examples of homoleptic compounds include compounds 21-24 and 35. Examples of heteroleptic compounds include compounds 25-34, 36 and 37.
[0039] In one aspect, [ka] The present invention provides a compound having a ligand L' selected from the group consisting of: R'1, R'2 and R'3 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl and heteroaryl.
[0040] In one embodiment, preferred are compounds in which an alkyl substituent (i.e., an alkyl substituent that results in a twist in the aryl substituent) is present on the pyridine ring of ligand L. Preferably, the compound is selected from the group consisting of compounds 21-23, 29-31, 34, 36, and 37.
[0041] In another embodiment, compounds in which the alkyl substituent is para to the nitrogen of the pyridine ring are particularly preferred. Preferably, the compound is selected from the group consisting of compounds 21, 22, 29-31, 34, 36 and 37.
[0042] Also provided is an organic light-emitting device having an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound having formula I as described above. The choices for the substituents described as being preferred for compounds having formula I are also preferred for devices comprising compounds having formula I. These choices include the metal M; the formulae II-VI; the substituents R, R1, R2, R3, R4, R5, and the R adjacent to the ring C. aincluding those described for the substituents; the position of ring C; and rings A, B and C.
[0043] In one embodiment, the device comprises a compound having formula II as described above. Preferably, the metal M is Ir. Preferably, A is pyridine. In another embodiment, the device comprises a compound having formula III or formula IV as described above. R1, R2, and R adjacent to C are a Also preferred are devices containing compounds in which only one of the substituents is alkyl. In yet another embodiment, the device contains a compound having formula V or formula VI as described above. Provided are specific devices containing a compound selected from the group consisting of compounds 21-37. Preferably, the device contains compound 21, compound 22, compound 25, compound 29, compound 30, compound 31 or compound 34.
[0044] In one embodiment, a device is provided in which the organic layer is an emissive layer and the compound having the formula of Formula I is an emissive dopant. Additionally, the organic layer can further comprise a host. Preferably, the host has the following structure: [ka] R'1, R'2, R'3, R'4, R'5 and R'6 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl and heteroaryl.
[0045] Also provided is a consumer product comprising a device. The device comprises an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound having Formula I as described above. The choices for the substituents described as preferred for the compound having Formula I are also preferred for use in the consumer product comprising the device comprising the compound having Formula I. These choices include the metal M; the substituents of Formulas II-VI; the substituents R, R1, R2, R3, R4, R5, and the ring C and adjacent R a including those described for the substituents; the position of ring C; and rings A, B and C.
[0046] Further provided is a low temperature method for making homoleptic compounds, in particular for making homoleptic Ir(III) compounds, which may preferably contain twisted aryls.
[0047] A first method for making homoleptic Ir(III) complexes is provided, the first method comprising: [ka] in the presence of a low boiling alcohol [ka] React with [ka] The method includes generating a signal.
[0048] R A and R B At least one of is an alkyl group, and the alkyl group is not adjacent to the nitrogen on the pyridine ring. S is a neutral ligand. X is a counterion. Preferably, X is a triflate. A and B are each independently a 5- or 6-membered carbocyclic or heterocyclic ring. AB is a nitrogen atom on ring A and a sp group on ring B. 2 R represents a bond pair of carbocyclic or heterocyclic rings coordinated to iridium through a hybridized carbon atom. A and R B Each of R can represent mono-, di-, tri- or tetra-substitution. A and R B are each independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl.
[0049] In one embodiment, the low boiling alcohol is selected from the group consisting of methanol, ethanol, n-propanol, isopropanol, n-butanol, ethanol and methanol in a 1:1 ratio, 2-methoxyethanol, and 2-ethoxyethanol. Preferably, the low boiling alcohol is selected from the group consisting of isopropanol, which boils at 108° C., ethanol, which boils at 78° C., and ethanol and methanol in a 1:1 ratio having boiling points of 65° C. and 78° C. More preferably, the low boiling alcohol is ethanol or ethanol and methanol in a 1:1 ratio. Most preferably, the low boiling alcohol is ethanol and methanol in a 1:1 ratio.
[0050] Preferably, A is [ka] It is.
[0051] C is a 5- or 6-membered carbocyclic or heterocyclic ring. AC represents a bonded pair of carbocyclic or heterocyclic rings. R A and R C can represent mono-, di-, tri- or tetra-substitutions. A and R C are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl. X1, X2, X3, X4, X5, X6, X7, X8, and X9 are independently selected from carbon and nitrogen. R1 and R2 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl. R1, R2, and the R adjacent to C are a At least one of the substituents is not hydrogen.
[0052] In one embodiment, the first method comprises: [ka] in the presence of a low boiling alcohol [ka] React with [ka] Certain compounds can be produced using this method, including compound 21, compound 22, and compound 24.
[0053] A second method for making homoleptic Ir(III) compounds is also provided. The second method comprises: [ka] in the absence of a solvent [ka] React with [ka] The method includes generating a signal.
[0054] R A and R B At least one of is an alkyl group, adjacent to the nitrogen on the pyridine ring. S is a neutral ligand. X is a counterion. Preferably, X is a triflate. A and B are each independently a 5- or 6-membered carbocyclic or heterocyclic ring. AB is a nitrogen atom on ring A and a sp group on ring B. 2 R represents a bond pair of carbocyclic or heterocyclic rings coordinated to iridium through a hybridized carbon atom. A and R B Each of R can represent mono-, di-, tri- or tetra-substitution. A and R B are each independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl.
[0055] Preferably, A is [ka] It is.
[0056] C is a 5- or 6-membered carbocyclic or heterocyclic ring. AC represents a bonded pair of carbocyclic or heterocyclic rings. R A and R C can represent mono-, di-, tri- or tetra-substitutions. A and R C are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl. X1, X2, X3, X4, X5, X6, X7, X8, and X9 are independently selected from carbon and nitrogen. R1 and R2 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl. R1, R2, and the R adjacent to C are a At least one of the substituents is not hydrogen.
[0057] In one embodiment, the second method comprises: [ka] in the absence of a solvent [ka] React with [ka] The method includes generating a signal. Certain compounds, including compound 23, can be produced using this method. [Brief description of the drawings]
[0058] [Figure 1] FIG. 1 illustrates an organic light-emitting device. [Diagram 2] FIG. 1 illustrates an inverted organic light emitting device that does not have a separate electron transport layer. [Diagram 3] FIG. 1 shows a PHOLED having a particular structure. [Figure 4]FIG. 1 illustrates a method for making heteroleptic Ir(III) compounds. [Diagram 5] FIG. 1 shows a heteroleptic Ir(III) complex with extended conjugation. [Figure 6] FIG. 1 illustrates a method for making heteroleptic Ir(III) compounds. [Figure 7] FIG. 1 shows twisted aryl-containing ligands and compounds containing twisted aryl-containing ligands. [Figure 8] FIG. 1 shows representative compounds. [Figure 9] FIG. 1 shows a method for making homoleptic Ir(III) compounds. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0059] In general, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes into the organic layer, and the cathode injects electrons into the organic layer. The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, they create an "exciton," a localized electron-hole pair with an excited energy state. Light is emitted when the exciton relaxes by a photoemissive mechanism. In some cases, the exciton can be localized on an excimer or exciplex. Non-radiative mechanisms, such as thermal relaxation, can also occur, but are generally considered undesirable.
[0060] Early OLEDs used emissive molecules that emitted light from their singlet state ("fluorescence"), such as those disclosed in U.S. Patent No. 4,769,292, which is incorporated by reference in its entirety. Fluorescence emission typically occurs on a time frame of less than 10 nanoseconds.
[0061] More recently, OLEDs have been shown to have emissive materials that emit light from triplet states ("phosphorescence"). Baldo et al., "Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices," Nature, vol. 395, pp. 151-154, 1998; ("Baldo-I") and Baldo et al., "Very high-efficiency green organic light-emitting devices based on electrophosphorescence," Appl. Phys. Lett., vol. 75, No. 3, pp. 4-6 (1999) ("Baldo-II"), which are incorporated herein by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704, paragraphs 5-6, which are incorporated herein by reference.
[0062] FIG. 1 illustrates an organic light-emitting device 100. These figures are not necessarily drawn to scale. Device 100 can include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, and a cathode 160. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 can be assembled by stacking these layers in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704, paragraphs 6-10, which are incorporated herein by reference.
[0063] Further examples of each of these layers can be obtained. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Patent No. 5,844,363, which is incorporated herein by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F.sub.4-TCNQ in a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003 / 0230980, which is incorporated herein by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Patent No. 6,303,238 to Thompson et al., which is incorporated herein by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li in a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003 / 0230980, which is incorporated herein by reference in its entirety. US Patent Nos. 5,703,436 and 5,707,745, which are incorporated herein by reference in their entirety, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag covered with a transparent conductive sputter-deposited ITO layer. The theory of blocking layers and their use are described in more detail in US Patent No. 6,097,147 and US Patent Application Publication No. 2003 / 0230980, which are incorporated herein by reference in their entirety. Examples of injection layers are provided in US Patent Application Publication No. 2004 / 0174116, which is incorporated herein by reference in its entirety. A description of protective layers can be found in US Patent Application Publication No. 2004 / 0174116, which is incorporated herein by reference in its entirety.
[0064] FIG. 2 shows an inverted OLED 200. The device comprises a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 can be assembled by stacking the above layers in order. Because the most common OLED structure has a cathode disposed above an anode, and device 200 has a cathode 215 disposed below anode 230, device 200 can be referred to as an "inverted" OLED. Materials similar to those described with respect to device 100 can be used for the corresponding layers of device 200. FIG. 2 shows an example of how some layers can be omitted from the structure of device 100.
[0065] The simplified layered structures illustrated in Figures 1 and 2 are provided by way of non-limiting example, with the understanding that embodiments of the present invention can be used in conjunction with a variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures can be used. A functional OLED can be achieved by combining the various layers otherwise described, or layers can be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described can also be included. Materials other than those specifically described can be used. While many of the examples provided herein describe the various layers as including a single material, it is understood that combinations of materials, such as a mixture of a host and a dopant, or more generally, mixtures, can be used. Also, the layers can have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into light-emitting layer 220, and can be referred to as a hole transport layer or a hole injection layer. In one embodiment, an OLED can be described as having an "organic layer" disposed between a cathode and an anode. The organic layer may include a single layer or may further include multiple layers made of different organic materials, for example as described with respect to FIGS.
[0066] Structures and materials not specifically described may also be used, such as OLEDs containing polymeric materials (PLEDs) as disclosed in U.S. Patent No. 5,247,190 to Friend et al., which is incorporated herein by reference in its entirety. As another example, OLEDs having a single organic layer may be used. For example, OLEDs may be stacked as described in U.S. Patent No. 5,707,745 to Forrest et al., which is incorporated herein by reference in its entirety. OLED structures may deviate from the simple layered structures illustrated in FIGs. 1 and 2. For example, the substrate may include angled reflective surfaces to improve outcoupling, such as the mesa structures described in U.S. Patent No. 6,091,195 to Forrest et al. and / or the recessed structures described in U.S. Patent No. 5,834,893 to Bulovic et al., which are incorporated herein by reference.
[0067] Unless otherwise specified, any of the layers of the various embodiments can be deposited by any suitable method. Preferred methods for organic layers include deposition by thermal evaporation, such as those described in U.S. Pat. Nos. 6,013,982 and 6,087,196 (which are incorporated herein by reference), inkjet, organic vapor phase deposition (OVPD), such as those described in U.S. Pat. No. 6,337,102 to Forrest et al. (which are incorporated herein by reference in their entirety), and organic vapor jet printing (OVJP), such as those described in U.S. Patent Application No. 10 / 233,470 (which are incorporated herein by reference in their entirety). Other suitable deposition methods include spin-coating and other solution-based processes. Solution-based processes are preferably carried out under nitrogen or an inert atmosphere. Preferred methods for other layers include thermal evaporation. Preferred patterning methods include deposition through a mask, such as those described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated herein by reference, cold welding, and patterning in conjunction with some of the deposition methods, such as inkjet and OVJD. Other methods can also be used. The materials to be deposited can be modified to make them compatible with the particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, can be used in small molecules to enhance their ability to undergo solution processing. Substituents with 20 or more carbons can be used, with 3-20 carbons being the preferred range. Materials with asymmetric structures can have better solution processability than materials with symmetric structures, since asymmetric materials have a lower tendency to recrystallize. Dendrimer substituents can be used to enhance the ability of small molecules to undergo solution processing.
[0068] Devices constructed according to embodiments of the invention can be incorporated into a wide range of consumer products including flat panel displays, computer monitors, television receivers, billboards, indoor or outdoor lighting and / or signaling lights, heads up displays, fully transparent displays, flexible displays, laser printers, telephones, mobile phones, personal digital assistants (PDAs), laptop computers, digital cameras, video cameras, viewfinders, microdisplays, vehicles, large area walls, theater or stadium screens or signs. A variety of control mechanisms including passive matrix and active matrix can be used to control devices constructed according to the invention. Many of the devices are intended for use in a temperature range that is comfortable for humans, such as 18°C to 30°C, and more preferably room temperature (20-25°C).
[0069] The materials and structures described herein have applications in devices other than OLEDs. For example, the materials and structures can be used in other optoelectronic devices, such as organic solar cells and organic photodetectors. More generally, the materials and structures can be used in organic devices, such as organic transistors.
[0070] The terms halo, halogen, alkyl, cycloalkyl, alkenyl, alkynyl, arylkyl, heterocyclic, aryl, aromatic and heteroaryl are known in the art and are defined in U.S. Pat. No. 7,279,704, paragraphs 31-32, which are incorporated herein by reference.
[0071] Compounds are provided that include heteroleptic Ir(III) complexes with extended conjugation. In particular, the complexes have extended conjugation on the heterocycle coordinated to the metal through nitrogen. Heteroleptic iridium complexes are of great interest because their photophysical, thermal and electronic properties can be tuned by the ligands attached to the metal center. One advantage of using heteroleptic iridium complexes is that they provide improved device lifetimes and lower sublimation temperatures compared to homoleptic Ir(III) complexes, thus improving manufacturing methods. For example, heteroleptic complexes including 2-phenylpyridine and 2-(biphenyl-3-yl)pyridine exhibit longer lifetimes compared to related homoleptic complexes. Furthermore, the sublimation temperatures of the heteroleptic complexes are almost 70° C. lower than the homoleptic complexes. See U.S. Provisional Application No. 60 / 940310. Heteroleptic complexes that exhibit improved stability and lower sublimation temperatures, such as those disclosed herein, are highly desirable for use in OLEDs. In particular, heteroleptic Ir(III) complexes are particularly desirable for use in white organic light emitting devices (WOLEDs).
[0072] Existing synthetic methods for making many heteroleptic iridium complexes are not very practical. In particular, existing synthetic routes include halogenation and further functionalization of iridium complexes (see Stossel et al., Rhodium complexes and iridium complexes, 2005, EP 1504015B1; Stossel et al., Rhodium and indium complexes, 2006, US Patent No. 7125998), the use of boronate ester-substituted iridium complexes obtained by halogenation and further functionalization (see Kwong et al., Method or synthesis of iridium(III) complexes with sterically demanding ligands, 2006, US Patent Application No. 12 / 044848), and the low-temperature BuLi / ZnCl2 method (see Huo et al., OLEDs with mixed ligand cyclometallated complexes, 2006, US Patent Application Publication No. 20060134459A1). The low temperature BuLi / ZnCl2 method, for example, produces the mer isomer of the complex, which is generally undesirable and must therefore be converted to the useful fac isomer of the complex. See Huo et al., OLEDs with mixed ligand cyclometallated complexes, 2006, US Patent Publication No. 20060134459A1. Thus, this method is not practical for large-scale synthesis of the complex. Although providing improved yields, the method involving the conversion of brominated iridium complexes to boronic esters to finally obtain the final product is not straightforward. See Kwong et al., Method for synthesis of iridium(III) complexes with sterically demanding ligands, 2006, US Patent Application No. 12 / 044848. Thus, it is particularly desirable to provide a more practical and straightforward synthetic method for making heteroleptic Ir(III) complexes.
[0073] The methods described herein can be used to make advantageous heteroleptic Ir(III) complexes for use in OLEDs, particularly WOLEDs. For example, the methods described herein can be used to make particularly desirable heteroleptic Ir(III) complexes, such as Compound 1, Compound 2, and Compound 7.
[0074] 1. A method for making an Ir(III) heteroleptic complex with extended conjugation, comprising: [ka] of, [ka] React with [ka] S is a neutral ligand; X is a counter ion; A and B are each independently a 5- or 6-membered aromatic or heteroaromatic ring; AB is a nitrogen atom on ring A and a sp 1 atom on ring B. 2 C and D each independently represent a 5- or 6-membered aromatic or heteroaromatic ring, and CD represents a bond between the nitrogen ring atom on ring C and the sp 2 R represents a bond pair of aromatic or heteroaromatic rings coordinated to iridium through a hybridized carbon atom. A , R B , R C and R D R is independently selected from the group consisting of unsubstituted, alkyl, heteroalkyl, aryl, or heteroaryl groups. A , R B , R C and R D Each of represents one or more substituents. R is an alkyl, heteroalkyl, or perfluoroalkyl group, where two R's are optionally joined to form a ring.
[0075] In one embodiment of this method, the counterion X is selected from the group consisting of triflate, tosylate, trifluoroacetate, tetrafluoroborate, and hexafluorophosphate.
[0076] In one embodiment, R A , R B , R C and R D is selected from the group consisting of benzene, pyrimidine, pyridine, thiophene, thianaphthene, fluorine, carbazole and dibenzothiophene.
[0077] In another aspect, the method further comprises: [ka] of, [ka] React with [ka] The method includes generating a signal.
[0078] In one embodiment of the method, the group B(OR)2 is attached to ring C. In another embodiment, the group B(OR)2 is attached to ring D. In a particular embodiment of the method, the group B(OR)2 is [ka] It is.
[0079] In one aspect, the method comprises: [ka] React with RX [ka] wherein R is aryl or heteroaryl and X is selected from the group consisting of I, Br, Cl and OTf.
[0080] In one aspect, the method comprises: [ka] of, [ka] React with [ka] In certain embodiments of the method, the complex [ka] teeth, [ka] In another embodiment, the complex is [ka] In yet another embodiment, the complex is [ka] It is.
[0081] In another aspect, the method further comprises: [ka] of, [ka] React with [ka] In certain embodiments of the method, the complex [ka] teeth, [ka] It is.
[0082] In another aspect, the method further comprises: [ka] of, [ka] React with [ka] In certain embodiments, the complex [ka] teeth, [ka] It is.
[0083] In another aspect, the method further comprises: [ka] of, [ka] React with [ka] In certain embodiments, the complex [ka] teeth, [ka] It is.
[0084] In yet another aspect, the method further comprises: [ka] of, [ka] React with [ka] In certain embodiments of the method, the complex [ka] teeth, [ka] It is.
[0085] In another aspect, the method further comprises: [ka] of, [ka] React with [ka] Generate [ka] React with AgX, [ka] and then [ka] of, [ka] React with [ka] The method further includes the step of generating:
[0086] Further provided are phosphorescent luminescent compounds. In particular, the compounds are Ir(III) heteroleptic complexes with extended conjugation on the heterocycle coordinated to the metal through the nitrogen. The compounds provided include the following: [ka]
[0087] The compound has a formula selected from the group consisting of:
[0088] Certain compounds are particularly beneficial. In one embodiment, the compound is preferably Compound 1. In another embodiment, the compound is preferably Compound 2.
[0089] The present invention provides heteroleptic iridium compounds which are advantageous for use in organic light emitting devices. In particular, the compounds are useful as emissive dopants in such devices. The heteroleptic compounds include [ka] is selected from the group consisting of:
[0090] Certain compounds are particularly beneficial. In one embodiment, the compound is preferably compound 8. In another embodiment, the compound is preferably compound 9. In yet another embodiment, the compound is preferably compound 10. In another embodiment, the compound is preferably compound 11. In yet another embodiment, the compound is preferably compound 12. In another embodiment, the compound is preferably compound 13. In yet another embodiment, the compound is preferably compound 14.
[0091] Further, an organic light-emitting device is provided that includes an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer being [ka] The device further comprises a compound selected from the group consisting of:
[0092] In one embodiment, the organic layer of the device further comprises a host. Compounds 1 and 2 have been found to work particularly well in devices having a host that includes a triphenylene group. In particular, these compounds are suitable for use in devices in which the host has the formula [ka] wherein R is aryl or heteroaryl. In certain embodiments, the host compound has the formula where R is terphenyl. Additionally, the compounds of the present invention are advantageously used in devices having the following structure: [ka] This is particularly useful in devices having
[0093] An organic light-emitting device is provided that includes an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising: [ka] The compound further comprises a compound selected from the group consisting of:
[0094] The organic layer of the device may further comprise a host. Compounds 7-12 have been found to work particularly well in devices having a host comprising a triphenylene group. In particular, these compounds are compounds in which the host is a compound of the formula: [ka] In one embodiment, the host compound has the formula above where R is terphenyl. Preferably, these compounds can be used in devices where the host has the structure [ka] In another embodiment, these compounds can be used in devices in which the host has the above formula where R is dibenzothiophene. Preferably, these compounds can be used in devices in which the host has the following structure: [ka] The present invention can be used in a device having
[0095] Also provided is a consumer product comprising a device, the device further comprising an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound selected from Compounds 1-6.
[0096] Also provided is a consumer product comprising a device further comprising an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer further comprising a compound selected from the group consisting of compounds 8-14.
[0097] As discussed above, existing synthetic methods for making heteroleptic iridium complexes may be impractical for making many compounds. One commonly used synthetic route involves reacting an iridium triflate intermediate with a second ligand in an organic solvent to give the heteroleptic iridium complex.
[0098] [ka]
[0099] However, this method often results in a mixture of products due to ligand disorder during the reaction. Specifically, the method produces both major and minor products in varying yields. The mixture of product compounds can cause problems in purifying the desired product, thus limiting the practical utility of this synthesis.
[0100] It is noteworthy that some of the heteroleptic iridium compounds provided herein (i.e., compounds 10, 11, and 14) can be obtained in high yield and without significant amounts of contaminating minor products by the triflate intermediate synthesis method when an alkyl-substituted triflate intermediate (e.g., 6'-methylphenylpyridine) is used. The very low degree of ligand disorder in the synthesis of compounds 10, 11, and 14 was unexpected, at least in part, because the same synthetic method did not produce the same results when used to make other compounds structurally similar to compound 11 (e.g., compound 2). See Example 8 and the Experimental Section.
[0101] Thus, provided herein is a method for making heteroleptic compounds with extended conjugation (exemplified in FIG. 6). The method comprises: [ka] of, [ka] React with [ka] S is a neutral ligand. X is a counter ion. A and B are each independently a 5- or 6-membered aromatic or heteroaromatic ring, and AB is a nitrogen atom on ring A and a sp 1 atom on ring B. 2 C and D each independently represent a 5- or 6-membered aromatic or heteroaromatic ring, and CD represents a bond between the nitrogen ring atom on ring C and the sp 2 R represents a bond pair of aromatic or heteroaromatic rings coordinated to iridium through a hybridized carbon atom. A , R B , R C and R D are each independently selected from the group consisting of unsubstituted, alkyl, heteroalkyl, aryl, or heteroaryl groups; RA , R B , R C and R D Each of R represents one or more substituents. Z is not H.
[0102] Preferably, the counterion X is selected from the group consisting of triflate, tosylate, trifluoroborate and hexafluorophosphate.
[0103] R A , R B , R C and R D is selected from the group consisting of benzene, pyrimidine, pyridine, thiophene, thianaphthene, fluorine, carbazole and dibenzothiophene. Z is preferably alkyl, more preferably R Z is methyl.
[0104] In one aspect, the method comprises: [ka] of, [ka] React with [ka] The method includes generating a signal.
[0105] Preferably, [ka] teeth, [ka] is selected from the group consisting of:
[0106] Instead of phenylpyridine as the AB ligand, this method involves the use of alkyl-substituted phenylpyridines (e.g., 6-methylphenylpyridine), which, when reacted with CD ligands, results in less disordered reaction products and therefore makes the products easier to purify. In particular, the above method was used to synthesize compounds 10, 11, and 14, resulting in high yields of the desired products with very little disordered contaminating products. After the reaction was completed, the reaction products were analyzed by chromatography. Specifically, in the crude precipitated products, the HPLC percentages of the major products for compounds 10, 11, and 14 were calculated to be 99.4%, 99.4, and 99.4%, respectively, and the combined HPLC percentages of the minor products were 0.3%, 0.5%, and 0.5%, respectively. On the other hand, the existing triflate intermediate method, i.e., L A-B If the 6-position of is not substituted, significant product disorder can occur. In particular, synthesis of compounds 2 and 7 using existing methods results in 92% and 91% major product, respectively, and 8% and 9% minor product, respectively, in the crude reaction mixture (as determined by HPLC). Thus, the above methods using alkyl-substituted phenylpyridine ligands provide an improved synthesis of heteroleptic compounds.
[0107] Furthermore, the formula Ir(L A-B )2(L C-D The present invention provides a heteroleptic compound having the formula: A-B teeth, [ka] It is. C-D teeth, [ka] R1, R2, R3, R4 and R5 are each independently selected from the group consisting of hydrogen and alkyl, and each of R1, R2, R3, R4 and R5 may represent mono-, di-, tri-, tetra- or penta-substitution. Preferably, R1, R2, R3, R4 and R5 are each independently selected from hydrogen and methyl.
[0108] Ligand L C-D is preferably [ka] is selected from the group consisting of:
[0109] 2-Phenylpyridine and alkyl-substituted 2-phenylpyridine ligands can provide beneficial properties. In particular, these ligands bind tightly to iridium(III). Thus, 2-phenylpyridine and alkyl-substituted 2-phenylpyridines provide good chemical stability. Furthermore, tris complexes of iridium and 2-phenylpyridine ligands evaporate at low temperatures (i.e., <250°C) under high vacuum. However, the operational stability of PHOLEDs using these complexes as emitters is poor and therefore needs to be improved. Aryl substitution on 2-phenylpyridine can improve device stability. Unfortunately, tris-iridium complexes of aryl-substituted 2-phenylpyridines evaporate only at high temperatures (i.e., >290°C). High evaporation temperatures are undesirable for long-term manufacturing due to decomposition. Thus, the use of such tris-aryl-substituted 2-phenylpyridines in PHOLEDs is limited. The heteroleptic compounds provided herein include two unsubstituted or alkyl-substituted 2-phenylpyridine ligands and one aryl-substituted 2-phenylpyridine ligand. Thus, the heteroleptic compounds provided herein can provide lower evaporation temperatures and improve device operating lifetimes.
[0110] In particular, compound 7, which has two 2-phenylpyridine ligands and one 2-(biphenyl-3-yl)pyridine ligand, shows improved stability in PHOLEDs compared to tris(2-phenylpyridine)iridium(III). The emission spectrum of compound 7 was slightly red-shifted. However, compared to tris(2-(biphenyl-3-yl)pyridine)iridium(III), its emission was blue-shifted. Taken together, this suggests that both ligands, i.e., 2-phenylpyridine and 2-(biphenyl-3-yl)pyridine, probably contribute to the emission. Furthermore, the oxidation and reduction properties of compound 7, tris(2-phenylpyridine)iridium(III) and tris(2-(biphenyl-3-yl)pyridine)iridium(III) were measured by cyclic voltammetry, and there was no significant difference between the values of the three different compounds. Therefore, the substitution pattern of this compound does not significantly shift the HOMO and LUMO levels of the complex.
[0111] The heteroleptic compounds Ir(L A-B )2(L C-D ) for ligand L C-D and ligand L A-B Combining Ir(L) provides better conjugation to the pyridine ring where the LUMO is located. Without wishing to be bound by theory, it is believed that the conjugation results in a significant reduction in the LUMO of the provided heteroleptic compound and stabilizes the pyridine ring. At the same time, the emission spectrum is improved by reducing the LUMO of the Ir(L) C-D )3, i.e., tris(2-phenylpyridine)iridium(III) with an aryl group on the pyridine. This is because the emission is L C-D Although dominated by L A-B is a non-emissive ligand. A-B )2(L C-D ) provides high device stability. The heteroleptic compounds Ir(L A-B )(L C-D )2, the effect is similar.
[0112] As discussed in the paragraph above, the synthesis of heteroleptic Ir(III) complexes can be improved by reacting a boronic acid ester functionalized ester directly with an iridium complex intermediate. This method is also shown in FIG. 4. In particular, this synthetic method is more useful for large-scale synthesis of the complexes. The reaction products can be separated by columns or other methods. Additionally, heteroleptic Ir(III) complexes with extended conjugation from the heterocycle can be made by the methods described herein. These compounds are also shown in FIG. 5. The use of these complexes in devices can result in improved stability and fabrication of the devices.
[0113] As discussed above, the synthesis of heteroleptic Ir(III) compounds can be improved by a method in which a substituted triflate iridium intermediate is reacted with a second ligand. This method is also illustrated in Figure 6. Notably, this synthesis can improve product purification by significantly reducing ligand disorder.
[0114] Novel compounds are provided that include at least one ligand that includes a twisted aryl (as shown in FIG. 7). Particular compounds provided include Ir(2-phenylpyridine) type compounds that include a twisted phenyl ring (as shown in FIG. 8). These twisted aryl compounds can be advantageously used in OLEDs to provide devices with improved efficiency, stability and fabrication. Preferably, these compounds can be used as emissive dopants in such devices.
[0115] Compounds containing twisted aryl groups have been reported in the literature (see, for example, US Patent Application Publication Nos. 2007 / 0003789 and 2009 / 0124805).
[0116] Although 2-phenylpyridine and alkyl-substituted 2-phenylpyridine ligands form iridium(III) compounds with good properties, these compounds have limitations for practical use in devices (e.g., poor operational stability). Although aryl substitution on 2-phenylpyridine improves device efficiency, tris-iridium compounds of aryl-substituted 2-phenylpyridine only evaporate at high temperatures (i.e., above 290° C.), which also limits the use of these compounds (i.e., decomposition during fabrication). 2-phenylpyridine-type ligands with specific substitution patterns have been found to be particularly beneficial. In particular, strategic combinations of alkyl and phenyl substitutions on 2-phenylpyridine-type ligands result in substituent aryl groups that are twisted out of the plane (i.e., twisted aryls), thereby reducing packing and lowering the evaporation temperature. The compounds provided herein include at least one ligand having alkyl and aryl substituents such that the substituent aryl is a twisted aryl. Thus, these compounds can provide lower evaporation temperatures, improve device fabrication, and improve device operating lifetimes.
[0117] The aryl groups substituted on the 2-phenylpyridine can also increase the conjugation of the ligand, thereby resulting in red-shifted emission. Such compounds having emission at longer wavelengths in the yellow portion of the spectrum, such as 540 nm to 580 nm, are of limited use because the emission is restricted to the yellow portion of the spectrum. Thus, compounds having emission in a different range, such as a blue-shifted range, are desirable. In particular, compounds having emission in a target energy range of about 521 nm to about 540 nm are particularly preferred. Compounds in which the substituent aryl ring is twisted by the addition of an alkyl group are believed to have limited conjugation and can exhibit blue-shifted emission. In particular, the twisted aryl compounds provided herein can have blue-shifted emission energies compared to corresponding compounds containing non-twisted aryl substituents. Thus, these blue-shifted compounds are particularly preferred.
[0118] Compounds are provided that include at least one ligand that includes a twisted aryl. To establish structure-property relationships for substituted Ir(2-phenylpyridine)-type phosphorescent materials and devices that include such materials, the effect of different twisted aryl substitution patterns on the emissive ligands was examined. Several aspects of material processability, including evaporation temperature, evaporation stability and solubility, as well as device properties of PHOLEDs using twisted phenyl containing compounds were examined. Strategically placed substituents present on the compounds can result in a twist of the substituent aryl ring. For example, a substituent present on the aryl group (i.e., ring C) or on the pyridine ring adjacent to the twisted aryl (i.e., ring A) can induce an additional twist of the aryl group. As a result, compounds with twisted aryl moieties can (i) provide reduced conjugation, thereby minimizing the red-shift effect typically associated with increased conjugation (i.e., the addition of phenyls), (ii) provide reduced stacking, thereby lowering the evaporation temperature and improving long-term thermal stability and processability, and (iii) provide narrow emission and therefore high luminous efficiency (i.e., high LE:EQE).
[0119] Compounds containing twisted aryls and a limited number of substituents (e.g., a single substituent) can improve stability while retaining the benefits of twisted aryls, such as improved efficiency and manufacturing. In addition, certain compounds provided herein exhibit particularly narrow emission, and thus can provide devices with particularly good emission efficiency, in addition to other notable improvements. Therefore, the compounds provided herein are particularly desirable.
[0120] Without wishing to be bound by theory, it is believed that compounds with only one substituent inducing a twist in the aryl substituent are particularly beneficial. In particular, compounds containing a single substituent inducing a twist in the aryl substituent are more stable than corresponding compounds containing multiple substituents. It is believed that compounds with a single substituent can have a smaller degree of twist between the aryl substituent and the remainder of the ligand and therefore more conjugation than compounds with multiple substituents that are twisted out of plane to a greater degree. In particular, it is believed that compounds with a single methyl substituent can have improved stability compared to compounds with multiple methyl substituents. For example, Device Example 28 and Device Comparative Example 6 have the same device structure and composition, except that Device Example 28 uses Compound 35 as the emissive dopant and Device Comparative Example 6 uses E4 as the emissive dopant. Both Compounds 35 and E4 are tris homoleptic compounds (i.e., IrL3) that contain a ligand with a twisted aryl group attached to the 5-position of 2-phenylpyridine. The only difference is that in E4 the aryl is a 2-methylphenyl group, whereas in compound 35 the aryl is 2,6-dimethylphenyl.
[0121] [ka]
[0122] The additional methyl group in E4 makes the twisted aryl more twisted than that in compound 35. The results (Table 8) show that the device containing compound 35 (Device Example 28, RT 80% =200 hours) was compared with the device containing E4 (Comparative Device Example 6, RT 80%=42 h). It is believed that more conjugated ligands can lead to more stable emissive dopants. Conjugation decreases in the series E3, 35 and E4 as the number of methyl groups increases from 0 to 1 to 2 (i.e., the twist between the pyridine and C ring increases). Therefore, it is reasonable to assume that the device containing E3 as the emissive dopant is more stable than the device containing compound 35 as the emissive dopant. However, the increased conjugation also causes a red shift in the emission of the corresponding Ir complex. Table 7 shows that E3 (Comparative Device Example 5) has a λ of 548 nm. max and (0.430, 0.560), whereas compound 35 (Device Example 28) has a λ max and CIE of (0.368, 0.607), and E4 (Comparative Device Example 6) has a λ max and CIE of (0.320, 0.632). Thus, E3 is more stable, but its emission is yellow, which is not suitable for full-color RGB displays. Compound 35 has conjugation between E3 and E4, achieving much improved stability over E4 (almost no conjugation) and better green color than E3 (too much conjugation).
[0123] The aryl substituents are twisted to form the following structure: [ka] The present invention provides compounds comprising a ligand L having alkyl and aryl substituents having the formula:
[0124] B and C are each independently a 5- or 6-membered carbocyclic or heterocyclic ring. AB is a nitrogen atom of ring A and a sp 2 Represents a bond pair of carbocyclic or heterocyclic rings coordinated to the metal M through a hybrid atom. AC represents a bond pair of carbocyclic or heterocyclic rings. R a , R b and R C can represent mono-, di-, tri- or tetra-substitutions.a , R b and R C are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl and heteroaryl. X1, X2, X3, X4, X5, X6, X7, X8 and X9 are independently selected from carbon and nitrogen. Preferably, A is pyridine. R1 and R2 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl and heteroaryl. R1, R2 and R adjacent to C are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl and heteroaryl. a At least one of the substituents is not hydrogen. Preferably, R, R, and R adjacent to C are a Only one of the substituents is not hydrogen. Preferably, R, R, and R adjacent to C are a Only one of the substituents is alkyl. More preferably, R, R, and R adjacent to C are a Only one of the substituents is ethyl. Most preferably, R, R and R adjacent to C are a Only one of the substituents is methyl. The ligand L is coordinated with a metal M having an atomic number greater than 40. Preferably, the metal M is Ir.
[0125] The following structure: [ka] The present invention provides certain compounds having the formula:
[0126] m is the oxidation state of the metal M. n is at least 1. L' is a monoanionic bidentate ligand. Preferably, R1, R2, and R adjacent to C are a Only one of the substituents is not hydrogen. Preferably, R, R, and R adjacent to C are a Only one of the substituents is alkyl. More preferably, R, R, and R adjacent to C are a Only one of the substituents is ethyl. Most preferably, R, R and R adjacent to C are aExactly one of the substituents is methyl.Preferably, A is pyridine.
[0127] Specific examples of compounds having formula II are provided, which compounds are [ka] is selected from the group consisting of:
[0128] R is not hydrogen. Preferably, R is alkyl.
[0129] Specific examples of compounds having formula II are provided. In one embodiment, the compounds are [ka] [ka] is selected from the group consisting of:
[0130] Preferably, the compound is selected from the group consisting of Compound 21, Compound 22, Compound 25, Compound 29, Compound 30, Compound 31 and Compound 34.
[0131] In one aspect, [ka] The present invention provides a compound selected from the group consisting of:
[0132] At least one of R1, R2, R3, and R4 is not hydrogen. R5 is selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl.
[0133] As discussed above, the twisting moiety of the substituent aryl ring (i.e., C ring) and adjacent substituents can result in the C ring being out of plane, thereby reducing packing and providing a wide range of tunability of evaporation temperature, solubility, energy levels, device efficiency and narrow emission spectrum. Furthermore, the substituents can be functional groups that are chemically and device-operationally stable.
[0134] In one embodiment, R1 and R2 are hydrogen and one of R3 and R4 is alkyl. Exemplary compounds include compounds 21-24, 29-34, 36, and 37. In another embodiment, one of R1 and R2 is alkyl and R3 and R4 are hydrogen. Exemplary compounds include compounds 25-28, and 35.
[0135] In another embodiment, the compound is [ka] is selected from the group consisting of:
[0136] Compounds having formula II include homoleptic and heteroleptic compounds. Non-limiting examples of homoleptic compounds include compounds 21-24 and 35. Non-limiting examples of heteroleptic compounds include compounds 25-34, 36 and 37.
[0137] The compound is [ka] Certain heteroleptic compounds are provided having a ligand L' selected from the group consisting of:
[0138] R'1, R'2 and R'3 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl and heteroaryl.
[0139] Preferred are twisted aryl-containing compounds with alkyl substituents present on the pyridine ring of the 2-phenylpyridine ligand, which also has an aryl substituent. In particular, preferred compounds selected from the group consisting of Compounds 21 to 23, Compounds 29 to 31, Compound 34, Compound 36, and Compound 37 are provided. More preferred compounds are Compounds 21, 22, Compounds 29 to 31, Compound 34, Compound 36, and Compound 37, which have an alkyl group at the 4-position of the 2-phenylpyridine ligand (i.e., para to the pyridine nitrogen), because such substitution provides a twist and also a slight blue-shift effect, allowing the compound to emit a deeper green color. For example, Device Example 13 has a λ of 525 nm. max and (0.342, 0.612), while Device Example 19 has a λ max and CIE of (0.372, 0.599). Example 13 employs compound 12 as an emissive dopant with a methyl group at the 4-position of the 2-phenylpyridine ligand, while Example 19 employs compound 25 as an emissive dopant with a methyl group at the 2-position of the twisted phenyl. The structurally induced twist in both cases is believed to be similar, but the methyl para to the pyridine nitrogen provides an electron donating effect, raising the LUMO energy level of the complex and also raising the triplet energy, thereby resulting in a blue shift in the emission.
[0140] Also provided is an organic light-emitting device having an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound having formula I as described above. The choices for the substituents described as preferred for compounds having formula I are also preferred for devices comprising compounds having formula I. These choices include the metal M; the substituents of formulas II-VI; R, R1, R2, and the R adjacent to ring C. a including those described for the substituents; the position of ring C; and rings A, B and C.
[0141] In one embodiment, the device comprises a compound having formula II as described above. Preferably, the metal M is Ir. Preferably, A is pyridine. In another embodiment, the device comprises a compound having formula III or formula IV as described above. R1, R2, and R adjacent to C are a Also preferred are devices containing compounds in which only one of the substituents is alkyl. In other embodiments, the device contains a compound having formula V or formula VI as described above. Particular devices are provided that contain a compound selected from the group consisting of compounds 21-37. Preferably, the device contains compound 21, compound 22, compound 25, compound 29, compound 30, compound 31, or compound 34.
[0142] In one embodiment, a device is provided in which the organic layer is an emissive layer and the compound having the formula of Formula I is an emissive dopant. Additionally, the organic layer can further comprise a host. Preferably, the host has the formula: [ka] wherein R'1, R'2, R'3, R'4, R'5, and R'6 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl.
[0143] Also provided is a consumer product that includes a device comprising a compound having Formula I, as described above. The device includes an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound having Formula I, as described above. The preferences for the substituents described as preferred for the compound having Formula I are also preferred for the consumer product that includes a device comprising a compound having Formula I. These preferences include the metal M; the substituents of Formulas II-VI; R, R1, R2, and C and adjacent R A including those described for the substituents; the position of ring C; and rings A, B and C.
[0144] Further, a novel method for making homoleptic Ir(III) compounds (shown in FIG. 9) is provided. A commonly used method for making homoleptic Ir(III) compounds involves heating a mixture of Ir(acac)3 and ligands in refluxing glycerol (about 180° C.) or without solvent at >230° C. Reactions at such high temperatures can cause problems such as thermal decomposition of the ligand and the resulting complex. Therefore, it is highly desirable to provide a novel method for making homoleptic Ir(III) compounds at lower temperatures. The above-mentioned methods can be used to make homoleptic Ir(III) compounds that are advantageous for use in OLEDs. In particular, a first method for making those with homoleptic Ir(III) compounds is provided. The first method can be used to synthesize compounds with alkyl groups that are not adjacent to the nitrogen in the heteroleptic ring of the ligand. For example, compounds 21, 22, and 24 can be synthesized using the first method provided. A second method for making homoleptic Ir(III) compounds is also provided. This second method can be used to synthesize compounds having an alkyl group adjacent to the nitrogen in the heterocycle of the ligand. For example, compound 23 can be synthesized using the second method provided.
[0145] A first method for making homoleptic Ir(III) complexes is provided, the first method comprising: [ka] in the presence of a low boiling alcohol [ka] React with [ka] The method includes generating a signal.
[0146] R A and R BAt least one of is an alkyl group, and the alkyl group is not adjacent to the nitrogen on the pyridine ring. S is a neutral ligand. X is a counterion. Preferably, X is a triflate. A and B are each independently a 5- or 6-membered carbocyclic or heterocyclic ring. AB is a nitrogen atom on ring A and a sp group on ring B. 2 R represents a bond pair of carbocyclic or heterocyclic rings coordinated to iridium through a hybridized carbon atom. A and R B Each of R can represent mono-, di-, tri- or tetra-substitution. A and R B are each independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl.
[0147] The low boiling alcohol can include any alcohol having a boiling point of 108° C. or less. In one aspect, the low boiling alcohol is selected from the group consisting of methanol, ethanol, n-propanol, isopropanol, n-butanol, ethanol and methanol in a 1:1 ratio, 2-methoxyethanol, and 2-ethoxyethanol. Preferably, the low boiling alcohol is selected from the group consisting of isopropanol, which boils at 108° C., ethanol, which boils at 78° C., and ethanol and methanol in a 1:1 ratio (boiling at 64° C. and 78° C.). More preferably, the low boiling alcohol is ethanol or ethanol and methanol in a 1:1 ratio. Most preferably, the low boiling alcohol is ethanol and methanol in a 1:1 ratio.
[0148] Preferably, A is [ka] It is.
[0149] C is a 5- or 6-membered carbocyclic or heterocyclic ring. AC represents a bonded pair of carbocyclic or heterocyclic rings. R A and R C can represent mono-, di-, tri- or tetra-substitutions.A and R C are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl. X1, X2, X3, X4, X5, X6, X7, X8, and X9 are independently selected from carbon and nitrogen. R1 and R2 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl. R1, R2, and the R adjacent to C are a At least one of the substituents is not hydrogen.
[0150] In one embodiment, the first method comprises: [ka] in the presence of a low boiling alcohol [ka] React with [ka] The method includes generating a signal.
[0151] Certain compounds, including compounds 21, 22 and 24, can be produced using this method.
[0152] A second method for making homoleptic Ir(III) compounds is provided, the second method comprising: [ka] in the absence of a solvent [ka] React with [ka] The method includes generating a signal.
[0153] R Aand R B At least one of is an alkyl group, adjacent to the nitrogen on the pyridine ring. S is a neutral ligand. X is a counterion. Preferably, X is a triflate. A and B are each independently a 5- or 6-membered carbocyclic or heterocyclic ring. AB is a nitrogen atom on ring A and a sp group on ring B. 2 R represents a bond pair of carbocyclic or heterocyclic rings coordinated to iridium through a hybridized carbon atom. A and R B Each of R can represent mono-, di-, tri- or tetra-substitution. A and R B are each independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl.
[0154] Preferably, A is [ka] It is.
[0155] C is a 5- or 6-membered carbocyclic or heterocyclic ring. AC represents a bonded pair of carbocyclic or heterocyclic rings. R A and R C can represent mono-, di-, tri- or tetra-substitutions. A and R C are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl. X1, X2, X3, X4, X5, X6, X7, X8, and X9 are independently selected from carbon and nitrogen. R1 and R2 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylkyl, aryl, and heteroaryl. R1, R2, and the R adjacent to C are a At least one of the substituents is not hydrogen.
[0156] In one embodiment, the second method comprises: [ka] in the absence of a solvent [ka] React with [ka] The method includes generating a signal.
[0157] Certain compounds, including compound 23, can be produced using this method. In particular, compound 23 can be synthesized by the following method: [ka] in the absence of a solvent at 130°C for 16 hours. [ka] React with [ka] It can be prepared using
[0158] The materials described herein as being useful for a particular layer in an organic light-emitting device can be used with a wide range of other materials present in the device.For example, the emissive dopants disclosed herein can be used with a wide range of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present.The materials described or referenced below are non-limiting examples of materials that are useful for use with the compounds disclosed herein.Those skilled in the art can easily consult the literature to identify other materials that are useful for use with them.
[0159] In addition to and / or together with the materials disclosed herein, many hole injection materials, hole transport materials, host materials, dopant materials, exciton / hole blocking layer materials, electron transport and electron injection materials can be used in OLEDs.Non-limiting examples of materials that can be used in OLEDs together with the materials disclosed herein are shown in Table 1 below.Table 1 lists non-limiting classes of materials, non-limiting examples of compounds for each class, and references that disclose the materials.
[0160] [Table 1A]
[0161] [Table 1B]
[0162] [Table 1C]
[0163] [Table 1D]
[0164] [Table 1E]
[0165] [Table 1F]
[0166] [Table 1G]
[0167] [Table 1H]
[0168] [Table 1I]
[0169] [Table 1J]
[0170] [Table 1K]
[0171] [Table 1L]
[0172] experiment Examples of Compounds Several heteroleptic Ir(III) complexes were synthesized as follows. EXAMPLES
[0173] Synthesis of compound 1 [ka] Synthesis of 2-phenyl-4-bromopyridine. A mixture of 2,4-dibromopyridine (10 g, 42.21 mmol), phenylboronic acid (5.1 g, 42.21 mmol) and potassium carbonate (11.7 g, 84.42 mmol) in 100 mL of dimethoxyethane and 40 mL of water was prepared. Nitrogen was bubbled directly into the mixture for 30 minutes. Tetrakis(triphenylphosphine)palladium(0) was then added (244 mg, 2.11 mmol) and the mixture was heated to reflux under nitrogen overnight. The mixture was cooled and diluted with ethyl acetate and water. The layers were separated and the aqueous layer was extracted with ethyl acetate. The organic layer was washed with brine, dried over magnesium sulfate, filtered and evaporated to give a residue. The residue was purified by column chromatography eluting with 0, 2 and 5% ethyl acetate / hexane. 4.28 g of a yellow liquid was obtained (43%).
[0174] [ka]
[0175] Synthesis of 2-phenyl-4(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pyridine. A mixture of 2-phenyl-4-bromopyridine (4.28 g, 18.28 mmol), bis(pinacolato)diboron (9.29 g, 36.57 mmol) and potassium acetate (5.38 g, 54.84 mmol) in 100 mL of dioxane was prepared. Nitrogen was bubbled directly into the mixture for 30 minutes. Dichloro[1,1'-ferrocenylbis(diphenylphosphine)]palladium(II) dichloromethane (448 mg, 0.55 mmol) was added and nitrogen was bubbled through for an additional 15 minutes. The reaction mixture was heated to an internal temperature of 90°C. After 1 hour the reaction was complete and the heat was turned off. The solvent was evaporated to give an oil. The oil was purified by Kugelrohr at 200°C to remove excess bis(pinacolato)diboron. The residue remaining in the boiling pot was dissolved in ethyl acetate, filtered through magnesium sulfate, rinsed with ethyl acetate, and the filtrate was evaporated to dryness. Used as described in the next step. Yield was about 4 g of product.
[0176] [ka]
[0177] Synthesis of PPY dimer. 14.7 g (0.04 mol) of iridium chloride and 26.0 g (0.17 mol) of 2-phenylpyridine were placed in a 1 L round bottom flask. 300 ml of 2-ethoxyethanol and 100 ml of water were added. The mixture was refluxed overnight under nitrogen atmosphere. After cooling to room temperature, the precipitate was filtered and washed with methanol. After drying, 22 g of dimer was obtained (yield 99%).
[0178] [ka]
[0179] Synthesis of triflate. 22 g of dimer was dissolved in 1 L of dichloromethane. 10.5 g (0.04 mol) of silver triflate was added to the solution. Then, 25 ml of methanol was added. The solution was stirred for 5 hours. The silver chloride was filtered off. The solution was evaporated to dryness. 26 g of product was obtained. The solid was used for the next step without further purification.
[0180] [ka]
[0181] Synthesis of borate precursor. A mixture of triflate (4.6 g, 7.11 mmol) and 2-phenyl-4(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pyridine (about 4 g, about 14.23 mmol) in 100 ml of ethanol was prepared. The mixture was heated at reflux under nitrogen for 6 hours. The solvent was evaporated and hexane was added. The solid was filtered off and washed with hexane. The solid was purified by column chromatography eluting with dichloromethane, after which some methanol was added. 0.92 g of an orange solid was obtained (about 17%).
[0182] [ka]
[0183] Synthesis of Compound 1. In 50 mL of toluene and 5 mL of water, the borate precursor (0.92 g, 1.18 mmol), bromobenzene (0.6 g, 3.54 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (19 mg, 0.047 mmol), and tripotassium phosphate (0.82 g, 3.54 mmol) were mixed. Nitrogen was bubbled directly into the mixture for 30 minutes, after which tris(dibenzylideneacetone)dipalladium(0) (11 mg, 0.0118 mmol) was added. Nitrogen was bubbled for an additional 5 minutes, and then the reaction mixture was heated to reflux under nitrogen for 1 hour. The mixture was cooled, and an orange solid precipitated. The solid was filtered off and washed with hexanes and then methanol. Some solid was found in the filtrate, so the filtrate was evaporated to dryness and methanol was added. A more orange solid was filtered off. All solids were purified by column chromatography eluting with 50% dichloromethane / hexanes. The solids were sublimed at 280° C. Yield 0.53 g (62%). EXAMPLES
[0184] Synthesis of compound 2 Compound 2 could be made using the following synthesis.
[0185] [ka]
[0186] Synthesis of 2-phenyl-5-bromopyridine. Prepare a mixture of 2,5-dibromopyridine (10 g, 42.21 mmol), phenylboronic acid (5.1 g, 42.21 mmol) and potassium carbonate (11.7 g, 84.42 mmol) in 100 mL of dimethoxyethane and 40 mL of water. Bubble nitrogen directly into the mixture for 30 minutes. Then add tetrakis(triphenylphosphine)palladium(0) (244 mg, 2.11 mmol) and heat the mixture to reflux under nitrogen overnight. Cool the mixture and dilute with ethyl acetate and water. Separate the layers and extract the aqueous layer with ethyl acetate. Wash the organic layer with brine, dry over magnesium sulfate, filter and evaporate to give a residue. Purify the residue by column chromatography eluting with 0, 2 and 5% ethyl acetate / hexane.
[0187] [ka]
[0188] Synthesis of 2-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine. Prepare a mixture of 2-phenyl-4-bromopyridine (4.28 g, 18.28 mmol), bis(pinacolato)diboron (9.29 g, 36.57 mmol) and potassium acetate (5.38 g, 54.84 mmol) in 100 mL of dioxane. Bubble nitrogen directly into the mixture for 30 minutes. Add dichloro[1,1'-ferrocenylbis(diphenylphosphine)]palladium(II) dichloromethane (448 mg, 0.55 mmol). Heat the reaction mixture to an internal temperature of 90° C. for 3 hours. Evaporate the solvent to obtain an oil. Purify the oil by Kugelrohr to remove excess bis(pinacolato)diboron. The residue remaining in the boiling pot is dissolved in ethyl acetate, filtered through magnesium sulfate, rinsed with ethyl acetate, and the filtrate is evaporated to dryness. This product can be used in the next step without purification.
[0189] [ka]
[0190] Synthesis of borate ester precursor. Prepare a mixture of triflate (4.6 g, 7.11 mmol) and 2-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pyridine (about 4 g, about 14.23 mmol) in 100 ml of ethanol. Heat the mixture at reflux under nitrogen for 24 hours. Evaporate the solvent and add hexane. Filter off the solid and wash with hexane. Purify the solid by column chromatography eluting with dichloromethane, then add some methanol.
[0191] [ka]
[0192] Synthesis of compound 2. Mix borate precursor (0.92 g, 1.18 mmol), bromobenzene (0.6 g, 3.54 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (19 mg, 0.047 mmol) and tripotassium phosphate (0.82 g, 3.54 mmol) in 50 mL toluene and 5 mL water. After bubbling nitrogen directly into the mixture for 30 minutes, add tris(dibenzylideneacetone)dipalladium(0) (11 mg, 0.0118 mmol). Bubble nitrogen for an additional 5 minutes, then heat the reaction mixture to reflux under nitrogen for 1 hour. Cool the mixture to form an orange solid. Filter off the solid and wash with hexane followed by methanol. Purify the solid by column chromatography eluting with 50% dichloromethane / hexane. EXAMPLES
[0193] Synthesis of compound 3
[0194] [ka]
[0195] Irppy intermediate (0.70 g, 0.90 mmol), 2-bromopyrimidine (0.71 g, 4.5 mmol), tris(dibenzylideneacetone)dipalladium(0) [Pd2(dba)3] (0.01 g, 1 mol%), tricyclohexylphosphine (0.05 g, 0.18 mmol) and tripotassium phosphate (K3PO4) (0.7 g, 3.3 mmol) were weighed into a 100 mL three-neck round bottom flask. 40 mL of toluene and 10 mL of water were added into the reaction vessel. The reaction mixture was degassed by bubbling nitrogen directly into the mixture for 1 h. The solution was heated to reflux for 2 h. After cooling, the product was filtered, dissolved in methylene chloride and chromatographed on silica gel with methylene chloride:hexane (50:50) as the mobile phase. The solvent was removed using a rotary evaporator and the product was dried under vacuum to give 0.6 g of product (90% yield). EXAMPLES
[0196] Synthesis of compound 4
[0197] [ka]
[0198] Irppy intermediate (1.0 g, 1.3 mmol), 2-bromopyridine (1.01 g, 6.4 mmol), tris(dibenzylideneacetone)dipalladium(0) [Pd2(dba)3] (0.05 g, 1 mol%), tricyclohexylphosphine (0.08 g, 5 mol%) and tripotassium phosphate (K3PO4) (4.0 g, 19.0 mmol) were weighed into a 100 mL three-neck round bottom flask. 50 mL of dioxane and 10 mL of water were added into the reaction vessel. The reaction mixture was degassed by bubbling nitrogen directly into the mixture for 1 h. The solution was heated to reflux for 2 h. After cooling, the product was filtered, dissolved in methylene chloride and chromatographed on silica gel with methylene chloride:hexane (50:50) as the mobile phase. The solvent was removed using a rotary evaporator and the product was dried under vacuum to give 0.8 g of product (86% yield). EXAMPLES
[0199] Synthesis of compound 5
[0200] [ka]
[0201] Irppy intermediate (1.50 g, 1.90 mmol), 3-bromothiophene (1.61 g, 9.6 mmol), tris(dibenzylideneacetone)dipalladium(0) [Pd2(dba)3] (0.02 g, 1 mol%), tricyclohexylphosphine (0.04 g, 4 mol%) and tripotassium phosphate (K3PO4) (1.2 g, 5.6 mmol) were weighed into a 250 mL three-neck round bottom flask. 100 mL toluene and 10 mL water were added into the reaction vessel. The reaction mixture was degassed by bubbling nitrogen directly into the mixture for 1 h. The solution was heated to reflux for 2 h. After cooling, the product was filtered, dissolved in methylene chloride and chromatographed on silica gel with methylene chloride:hexane (50:50) as the mobile phase. The solvent was removed using a rotary evaporator and the product was dried under vacuum to give 1.0 g of product (74% yield). EXAMPLES
[0202] Synthesis of compound 6
[0203] [ka]
[0204] Irppy intermediate (1.50 g, 1.90 mmol), 3-bromothianaphthene (2.0 g, 9.6 mmol), tris(dibenzylideneacetone)dipalladium(0) [Pd2(dba)3] (0.08 g, 1 mol%), tricyclohexylphosphine (0.2 g, 0.5 mmol) and tripotassium phosphate (K3PO4) (1.2 g, 5.6 mmol) were weighed into a 250 mL three-neck round bottom flask. 100 mL of toluene and 10 mL of water were added into the reaction vessel. The reaction mixture was degassed by bubbling nitrogen directly into the mixture for 1 h. The solution was heated to reflux for 2 h. After cooling, the product was filtered, dissolved in methylene chloride and chromatographed on silica gel with methylene chloride:hexane (50:50) as the mobile phase. The solvent was removed using a rotary evaporator and the product was dried under vacuum to give 1.2 g of product (80% yield). EXAMPLES
[0205] Synthesis of compound 7
[0206] [ka]
[0207] Synthesis of 2-(3-bromophenyl)pyridine. 2-Bromopyridine (75.0 g, 475 mmol), 3-bromophenylboronic acid (104.8 g, 520 mmol), palladium acetate (2.6 g, 2.5 mol%), triphenylphosphine (5.37 g, 5 mol%) and potassium carbonate (196.0 g, 1425 mmol) were placed in a 2 L three-necked round bottom flask. 500 mL of dimethoxyethane and 500 mL of H2O were added to the flask. Nitrogen was bubbled through the solution for 30 minutes and then the solution was refluxed under nitrogen atmosphere for 8 hours. The reaction was then cooled to room temperature and the organic phase was separated from the aqueous phase. The aqueous phase was washed with ethyl acetate, the organic fractions were combined, dried over magnesium sulfate and the solvent was removed under vacuum. The product was chromatographed using silica gel with ethyl acetate and hexane as eluents. The solvent was removed to give 84.0 g of a clear oil (76% yield).
[0208] [ka]
[0209] Synthesis of 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine. 2-(3-Bromophenyl)pyridine (25.0 g, 107 mmol), bis(pinacolato)diboron (54.2 g, 214 mmol), Pd(dppf)2Cl2 (1.0 g, 10 mol%) and potassium acetate (31.5 g, 321 mmol) were placed in a 1 L round bottom flask. 600 mL of dioxane was then added to the flask. Nitrogen was bubbled through the reaction mixture for 1 hour and then the flask was heated to 90° C. under nitrogen atmosphere for 12 hours. Dioxane was removed under reduced pressure on a rotary evaporator. The dark solid was dissolved in 400 mL of dichloromethane and passed through a 2 inch thick plug of silica gel. The dichloromethane was removed by rotary evaporation leaving a yellow oil, and the product was then distilled using a Kugelrohr apparatus to give 23 g of a white solid (77% yield).
[0210] [ka]
[0211] Synthesis of Irppy intermediate. Irppy triflate (17.5 g, 25 mmol) and 3 molar equivalents of 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine (21.50 g, 117 mmol) were placed in a 2 L three-neck round bottom flask. 600 mL of alcohol was added to the reaction mixture. The reaction mixture was degassed by bubbling nitrogen directly into the mixture for 1 h. The reaction mixture was then refluxed overnight (the internal temperature of the reaction mixture was 78°C). After about 18 h, the product had already precipitated from the hot reaction mixture. After cooling to room temperature, 200 mL of isopropanol was added to further precipitate the product from the reaction mixture. The reaction mixture was then filtered and the product / residue was washed with isopropanol (to remove excess ligand) and then air dried to give 12 g of product (60% yield).
[0212] [ka]
[0213] Synthesis of Compound 7. Irppy intermediate (0.50 g, 0.64 mmol), bromobenzene (0.5 g, 3.2 mmol), tris(dibenzylideneacetone)dipalladium(0) [Pd2(dba)3] (0.006 g, 0.0064 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (0.10 g, 0.025 mmol) and tripotassium phosphate (K3PO4) (0.4 g, 1.92 mmol) were weighed into a 100 mL three-neck round-bottom flask. 40 mL of toluene and 10 mL of water were added to the reaction vessel. The reaction mixture was degassed by bubbling nitrogen directly into the mixture for 1 h. The solution was heated to reflux for 2 h. After cooling, the product was filtered, dissolved in methylene chloride and chromatographed on silica gel with methylene chloride:hexane (50:50) as the mobile phase. The solvent was removed using a rotary evaporator and the product was dried under vacuum to give 0.5 g of product (95% yield). EXAMPLES
[0214] Synthesis of compound 2 The following alternative synthesis was used to make compound 2.
[0215] [ka]
[0216] Synthesis of 2,5-diphenylpyridine. 2,5-Dibromopyridine (10 g, 42 mmol), phenylboronic acid (13.4 g, 110 mmol), dicyclohexyl(2',6'-dimethoxybiphenyl-2-yl)phosphine (S-Phos) (0.7 g, 1.6 mmol) and potassium phosphate (22 g, 105 mmol) were mixed in 200 mL toluene and 20 mL water. Nitrogen was bubbled directly into the mixture for 30 minutes. Pd2(dba)3 was then added (0.38 g, 0.4 mmol) and the mixture was heated to reflux under nitrogen for 2 hours. The mixture was cooled and the organic layer was separated. The organic layer was washed with brine, dried over magnesium sulfate, filtered and evaporated to give a residue. The residue was purified by column chromatography eluting with 10% ethyl acetate / hexane. 7 g of the desired product was obtained after purification (yield 91.8%).
[0217] [ka]
[0218] Synthesis of compound 2. Iridium triflate precursor (2.5 g, 3.5 mmol) and 2,5-diphenylpyridine (2.4 g, 11 mmol) were mixed in 200 mL of ethanol. The mixture was heated at reflux under nitrogen for 24 h. A precipitate formed during reflux. The reaction mixture was filtered through a bed of celite. The product was washed with methanol and hexane. The solid was dissolved in dichloromethane and purified by column with 1:1 dichloromethane and hexane. 1.2 g of pure product was obtained after column purification. (HPLC purity 99.8%) EXAMPLES
[0219] Alternative synthesis of compound 7 The following alternative synthesis was used to make compound 2.
[0220] [ka]
[0221] Iridium triflate precursor (2.5 g, 3.5 mmol) and 2-(biphenyl-3-yl)pyridine (2.4 g, 11 mmol) were mixed in 200 mL of ethanol. The mixture was heated at reflux under nitrogen for 24 h. A precipitate formed during reflux. The reaction mixture was filtered through a bed of celite. The product was washed with methanol and hexane. The solid was dissolved in dichloromethane and purified by column with 1:1 dichloromethane and hexane. 1.5 g of pure product was obtained after column purification. (HPLC purity 99.6%) EXAMPLES
[0222] Synthesis of compound 8
[0223] [ka]
[0224] Iridium triflate precursor (2.5 g, 3.5 mmol) and 2-(biphenyl-4-yl)pyridine (2.4 g, 11 mmol) were mixed in 100 mL of ethanol. The mixture was heated at reflux under nitrogen for 24 h. A precipitate formed during reflux. The reaction mixture was filtered through a bed of celite. The product was washed with methanol and hexane. The solid was dissolved in dichloromethane and purified by column with 1:1 dichloromethane and hexane. 1.2 g of pure product was obtained after column purification. (HPLC purity 99.8%) EXAMPLES
[0225] Synthesis of compound 9
[0226] [ka]
[0227] Iridium triflate precursor (2.5 g, 3.5 mmol) and 2-(biphenyl-4-yl)-4-methylpyridine (2.6 g, 11 mmol) were mixed in 100 mL of ethanol. The mixture was heated at reflux under nitrogen for 24 h. A precipitate formed during reflux. The reaction mixture was filtered through a bed of celite. The product was washed with methanol and hexane. The solid was dissolved in dichloromethane and purified by column with 1:1 dichloromethane and hexane. 1.3 g of pure product was obtained after column purification. (HPLC purity 99.9%) EXAMPLES
[0228] Synthesis of compound 10
[0229] [ka]
[0230] Iridium triflate precursor (2.0 g, 2.7 mmol) and 2-(biphenyl-4-yl)-4-methylpyridine (2.0 g, 8.2 mmol) were mixed in 60 mL of ethanol. The mixture was heated at reflux under nitrogen for 24 h. A precipitate formed during reflux. The reaction mixture was filtered through a bed of celite. The product was washed with methanol and hexane. The solid was dissolved in dichloromethane and purified by column with 1:1 dichloromethane and hexane. 1.6 g of pure product was obtained after column purification. (HPLC purity 99.4%) EXAMPLES
[0231] Synthesis of compound 11
[0232] [ka]
[0233] Iridium triflate precursor (1.2 g, 1.6 mmol) and 2,5-diphenylpyridine (1.2 g, 4.8 mmol) were mixed in 50 mL of ethanol. The mixture was heated at reflux under nitrogen for 24 h. A precipitate formed during reflux. The reaction mixture was filtered through a bed of celite. The product was washed with methanol and hexane. The solid was dissolved in dichloromethane and purified by column with 1:1 dichloromethane and hexane. 1.0 g of pure product was obtained after column purification. (HPLC purity 99.3%)
[0234] As shown for compound 11, the reaction of an iridium triflate intermediate with a second ligand in an organic solvent often produces mixtures due to ligand scrambling during the reaction. Interestingly, no significant scrambling occurred during the synthesis of compound 11.
[0235] However, synthesis of compound 7 using this method resulted in significant scrambling despite the structural similarity between compounds 11 and 7 (i.e., compound 11 is identical to compound 7 except for the methyl group on the phenylpyridine ligand). Specifically, the iridium triflate intermediate was reacted with 2,5-diphenylpyridine under reflux conditions in ethanol. The product was a mixture of compound 7 and two other scrambled products, as shown below. Due to the similar polarity of the compounds, it is very difficult to separate these impurities from compound 7 using normal phase silica gel chromatography.
[0236] [ka] EXAMPLES
[0237] Synthesis of compound 12
[0238] [ka]
[0239] Iridium triflate precursor (2.5 g, 3.5 mmol) and 4-methyl-2,5-biphenylpyridine (2.6 g, 10.5 mmol) were mixed in 100 mL of ethanol. The mixture was heated at reflux under nitrogen for 24 h. A precipitate formed during reflux. The reaction mixture was filtered through a bed of celite. The product was washed with methanol and hexane. The solid was dissolved in dichloromethane and purified by column with 1:1 dichloromethane and hexane. 1.2 g of pure product was obtained after column purification. (HPLC purity 99.9%) EXAMPLES
[0240] Synthesis of compound 13
[0241] [ka]
[0242] Iridium triflate precursor (2.5 g, 2.7 mmol) and 2-(biphenyl-4-yl)-6-methylpyridine (2.0 g, 8.1 mmol) were placed in a 20 mL reaction tube. The reaction tube was evacuated and then backfilled with nitrogen. This process was repeated three times. The mixture was heated to 130° C. under nitrogen for 24 hours. The reaction mixture was dissolved in dichloromethane and purified by column with 1:1 dichloromethane and hexane. 0.98 g of pure product was obtained after column purification. (HPLC purity 99.8%) EXAMPLES
[0243] Synthesis of compound 14
[0244] [ka]
[0245] Iridium triflate precursor (0.86 g, 1.15 mmol) and 4-methyl-2,5-diphenylpyridine (0.85 g, 3.46 mmol) were mixed in 30 mL of ethanol. The mixture was heated at reflux under nitrogen for 24 h. A precipitate formed during reflux. The reaction mixture was filtered through a bed of celite. The product was washed with methanol and hexane. The solid was dissolved in dichloromethane and purified by column with 1:1 dichloromethane and hexane. 0.7 g of pure product was obtained after column purification. (HPLC purity 99.5%)
[0246] As shown for compound 11, the reaction of the iridium triflate intermediate with a second ligand in an organic solvent often produces a mixture of products due to ligand scrambling during the reaction. Interestingly, no significant scrambling occurred during the synthesis of compounds 10, 11, and 14. The content of the desired product in the precipitate was greater than 99% in all cases.
[0247] Notably, the synthesis of compound 7 using this method resulted in significant scrambling, despite the structural similarity between compounds 11 and 7 (i.e., compound 11 is identical to compound 7 except for the methyl group on the phenylpyridine ligand). Specifically, the iridium triflate intermediate was reacted with 2,5-diphenylpyridine under reflux conditions in ethanol. The product was a mixture of compound 7 and two other scrambled products, as shown below. Due to the similar polarity of the compounds, it is very difficult to separate these impurities from compound 7 using normal phase silica gel chromatography. EXAMPLES
[0248] Synthesis of compound 21
[0249] [ka]
[0250] Synthesis of 2,5-diphenyl-4-methylpyridine. Phenylboronic acid (72.9 g, 598 mmol), 2,5-dibromo-4-methylpyridine (50 g, 199 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (3.3 g, 8 mmol), tripotassium phosphate monohydrate (137 g, 595 mmol), toluene 650 mL, and water 150 mL were placed in a 2 L round bottom flask. Nitrogen was bubbled directly into the mixture for 30 minutes, after which tris(dibenzylideneacetone)dipalladium(0) (1.79 g, 1.96 mmol) was added. Nitrogen was bubbled into the reaction mixture for an additional 15 minutes, and the reaction mixture was heated to reflux under nitrogen for 16 hours. After the reaction was complete, the mixture was cooled and the organic layer was separated from the aqueous layer. The organic layer was washed with saturated brine solution and then dried over magnesium sulfate. The solution was filtered and the solvent was removed under vacuum to give a yellow solid as crude product. The crude product was purified by column chromatography using silica gel as stationary phase and 10% ethyl acetate in hexane as mobile phase. The product was further purified by recrystallization from hexane. 42.6 g of the desired product was obtained after purification (yield 87.2%).
[0251] [ka]
[0252] Synthesis of Ir dimer. IrCl3·3H2O (7.54 g, 20.4 mol) and 2,5-diphenyl-4-methylpyridine (15.0 g, 61 mol) were placed in a 1 L round bottom flask. Then 100 mL of 2-ethoxyethanol and 35 mL of water were added. The mixture was refluxed under nitrogen for 16 h. The reaction mixture was cooled to room temperature and the precipitate was filtered and washed with methanol and then hexane. 13.6 g of iridium dimer was obtained (99% yield).
[0253] [ka]
[0254] Synthesis of Ir triflate. 13.3 g of iridium dimer was dissolved in 1.5 L of dichloromethane. Silver triflate (5.11 g, 19.9 mmol) was dissolved in 500 mL of isopropanol and added to the iridium dimer solution. The resulting mixture was stirred at room temperature for 18 hours. The solution was then poured through a plug of Celite to remove silver chloride, and the solvent was evaporated under vacuum to give 17.0 g of iridium triflate. The solid was used for the next step without further purification.
[0255] [ka]
[0256] Synthesis of Compound 21. Iridium triflate (17.0 g, 17.9 mol) and 3 molar equivalents of 2,5-diphenyl-4-methylpyridine (13.1 g, 53.7 mmol) were placed in a 1 L round bottom flask. 150 mL of ethanol was added and the reaction mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×50 mL) followed by hexane (2×50 mL). The product was then eluted through a plug of silica with dichloromethane. Most of the dichloromethane was removed under vacuum and the product was precipitated with 2-propanol, filtered, washed with hexane and dried to give 9.69 g of product (90.6% yield). EXAMPLES
[0257] Synthesis of compound 22
[0258] [ka]
[0259] Synthesis of 2-amino-4-ethyl-5-iodopyridine. 4-Ethyl-2-aminopyridine (10.0 g, 81.9 mmol) and potassium acetate (8.00 g, 81.9 mmol) were dissolved in 100 mL of acetic acid and heated to 80° C. with continuous stirring. In a separate flask, iodine monochloride (13.2 g, 81.9 mmol) was dissolved in 30 mL of acetic acid and added dropwise to the above reaction mixture. Upon completion of the addition, the reaction mixture was heated for an additional 4 hours. The progress of the reaction was monitored by gas chromatography and HPLC. Upon completion of the reaction, the reaction mixture was cooled to room temperature and quenched with saturated aqueous sodium bisulfite solution (10 mL). Acetic acid was removed under vacuum and the residue was dissolved in ethyl acetate and neutralized with saturated NaHCO3. The organic layer was separated from the aqueous layer and the solvent was removed under vacuum. The crude product was purified by silica gel column chromatography eluting with 25% ethyl acetate / hexane. 15 g of the desired product was obtained (74% yield).
[0260] [ka]
[0261] Synthesis of 2-chloro-4-ethyl-5-iodopyridine. 4-Ethyl-5-iodopyridin-2-amine (15.0 g, 60.48 mmol) was dissolved in 140 mL of concentrated HCl. NaNO2 was dissolved in 40 mL of water and added dropwise to the above solution at 0° C. Care was taken to prevent the temperature of the reaction mixture from rising above 0° C. Once all the NaNO2 solution was added, the reaction mixture was warmed to room temperature and stirred at room temperature for an additional 2 hours. The progress of the reaction was monitored by GC and HPLC. The reaction mixture was then re-cooled to 0° C. and the pH was adjusted to pH=12 by adding saturated NaOH. The mixture was extracted with dichloromethane (2×200 mL) and the solvent was removed under vacuum. The crude product was purified by silica gel column chromatography eluting with 5% ethyl acetate / hexane. 8.0 g of the desired product was obtained after purification (49% yield).
[0262] [ka]
[0263] Synthesis of 2,5-diphenyl-4-ethylpyridine. Phenylboronic acid (11.0 g, 90 mmol), 2-chloro-4-ethyl-5-iodopyridine (8.00 g, 30 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (492 mg, 1.2 mmol), tripotassium phosphate (20.7 g, 90 mmol), 250 mL toluene and 25 mL water were placed in a 1 L round bottom flask. Nitrogen was bubbled directly into the mixture for 30 minutes, after which tris(dibenzylideneacetone)dipalladium(0) (275 mg, 0.3 mmol) was added. Nitrogen was bubbled for an additional 15 minutes, and then the reaction mixture was heated to reflux under nitrogen for 16 hours. After the reaction was complete, the mixture was cooled and the organic layer was separated from the aqueous layer. The organic layer was washed with saturated brine solution and dried over magnesium sulfate. The solution was filtered and the solvent was removed under vacuum to give an off-white solid. The crude product was purified by silica gel column chromatography eluting with 10% ethyl acetate / hexane. 7.0 g of the desired product was obtained after purification (yield 90.9%).
[0264] [ka]
[0265] Synthesis of Ir dimer. IrCl3·3H2O (1.5 g, 4.41 mmol) and 2,5-diphenyl-4-ethylpyridine (4.0 g, 15.44 mmol) were placed in a 250 mL round bottom flask. 30 mL of 2-ethoxyethanol and 10 mL of water were added. The mixture was refluxed under nitrogen for 16 h. The reaction mixture was then cooled to room temperature and the precipitate was filtered and washed with methanol and then hexane. After drying, 2.57 g of iridium dimer was obtained (yield 81%).
[0266] [ka]
[0267] Synthesis of Ir triflate. Iridium dimer (2.57 g, 1.725 mmol) was dissolved in 250 mL of dichloromethane. Silver triflate (1.0 g, 3.8 mmol) was dissolved in 150 mL of 2-propanol and added to the dimer solution. The resulting mixture was stirred for 5 hours. The solution was then poured through a plug of Celite to remove the silver chloride. The solvent was evaporated under vacuum to give 3.2 g of iridium triflate. The solid was used for the next step without further purification.
[0268] [ka]
[0269] Synthesis of Compound 22. Iridium triflate (3.2 g) and 2,5-diphenyl-4-ethylpyridine (3.2 g) were placed in a 250 mL round bottom flask. 50 mL of ethanol was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch bed of silica gel. The silica bed was then washed twice with ethanol (2×100 mL) followed by hexane (2×100 mL). The product was then eluted through a plug of silica with dichloromethane. Most of the dichloromethane was removed under vacuum and the product was precipitated with 2-propanol, filtered, washed with hexane and dried to give 1.67 g of product (52.8% yield). EXAMPLES
[0270] Synthesis of compound 23
[0271] [ka]
[0272] Synthesis of 2,5-diphenyl-6-methylpyridine. Phenylboronic acid (24.3 g, 199.25 mmol), 2,5-dibromo-6-methylpyridine (10 g, 39.85 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (654 mg, 1.5 mmol), tripotassium phosphate (27.5 g, 119.5 mmol), toluene 300 mL, and water 30 mL were placed in a 1 L round bottom flask. Nitrogen was bubbled directly into the mixture for 30 minutes, after which tris(dibenzylideneacetone)dipalladium(0) (364 mg, 0.398 mmol) was added. Nitrogen was bubbled for an additional 15 minutes, and then the reaction mixture was heated to reflux under nitrogen for 16 hours. After the reaction was complete, the mixture was cooled and the organic layer was separated. The organic layer was washed with saturated brine solution and dried over magnesium sulfate. The solution was filtered and the solvent was removed under vacuum. The crude product was purified by column chromatography using silica gel as stationary phase and 10%-20% ethyl acetate in hexane as mobile phase. 9.0 g of the desired product was obtained after purification (yield 92.7%).
[0273] [ka]
[0274] Synthesis of Ir dimer. IrCl3·3H2O (1.6 g, 4.66 mmol) and 2,5-diphenyl-6-methylpyridine (4.0 g, 16.31 mmol) were placed in a 250 mL round bottom flask. 45 mL of 2-ethoxyethanol and 15 mL of water were added. The mixture was refluxed under nitrogen for 16 h. The reaction mixture was then allowed to cool to room temperature. The precipitate was filtered and washed with methanol and then hexane. After drying, 2.75 g of dimer was obtained (yield 84.6%).
[0275] [ka]
[0276] Synthesis of Ir triflate. Iridium dimer (2.75 g, 2.2 mmol) was dissolved in 200 mL of dichloromethane. Silver triflate (1.19 g, 4.6 mmol) was dissolved in 100 mL of methanol and added to the iridium dimer solution. The resulting mixture was stirred for 5 hours. The solution was then poured through a plug of celite to remove the silver chloride. The solvent was evaporated under vacuum to give 3.5 g of iridium triflate. The solid was used for the next step without further purification.
[0277] [ka]
[0278] Synthesis of compound 23. Iridium triflate (3.0 g) and 2,5-diphenyl-6-methylpyridine (3.0 g) were placed in a 100 mL round bottom flask. The solid mixture was heated to 130° C. for 16 hours. After cooling, the reaction mixture was dissolved in 200 mL of dichloromethane. The solution was then poured through a 2-inch plug of silica gel. The solvent was removed under vacuum and the residue was chromatographed using silica gel with dichloromethane as the mobile phase. Most of the solvent was evaporated and the product was precipitated with 2-propanol, filtered, washed with hexane, and then dried to give 2.65 g of product (71% yield). EXAMPLES
[0279] Synthesis of compound 24
[0280] [ka]
[0281] Synthesis of 2,5-(m-tolyl(-4-methylpyridine). m-Tolyl borate (17.9 g, 132 mmol), 2,5-dibromo-4-methylpyridine (11.0 g, 44.0 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (726 mg, 1.77 mmol), potassium phosphate tripotassium monohydrate (30 g, 130 mmol), 143 mL of toluene, and 33 mL of water were placed in a 500 mL round-bottom flask. After bubbling nitrogen directly into the mixture for 30 minutes, tris(dibenzylideneacetone)dipalladium(0) ( To the reaction mixture was added 394 mg (43 mmol). Nitrogen was bubbled for an additional 15 min and then the reaction mixture was heated to reflux under nitrogen for 16 h. The mixture was cooled to room temperature and the organic layer was separated from the aqueous layer. The organic layer was washed with saturated brine solution and dried over magnesium sulfate. The solution was filtered and the solvent was removed under vacuum to give an off-white product. The crude product was purified by column chromatography using silica gel as the stationary phase and 10% ethyl acetate in hexane as the mobile phase. 11.2 g of the desired product was obtained after purification (yield 93.3%).
[0282] [ka]
[0283] Synthesis of Ir dimer. IrCl3·3H2O (1.8 g, 4.86 mmol) and 2,5-ditolyl-4-methylpyridine (4.0 g, 14.6 mmol) were placed in a 100 mL round bottom flask. 24 mL of 2-ethoxyethanol and 8 mL of water were added. The mixture was refluxed under nitrogen for 16 h. The reaction mixture was then cooled to room temperature. The precipitate was filtered and washed with methanol and then hexane. After drying, 3.0 g of iridium dimer was obtained (79.6% yield).
[0284] [ka]
[0285] Synthesis of Ir triflate. 3.0 g of iridium dimer was dissolved in 380 mL of dichloromethane. Silver triflate (1.0 g, 4.08 mmol) was dissolved in 20 mL of isopropanol and added to the iridium dimer solution. The resulting mixture was stirred for 5 hours. The solution was then poured through a plug of Celite to remove the silver chloride. The solvent was evaporated under vacuum to give 2.7 g of iridium triflate. The solid was used for the next step without further purification.
[0286] [ka]
[0287] Synthesis of Compound 24. Iridium triflate (2.7 g, 2.95 mmol) and 2,5-ditolyl-4-methylpyridine (3.6 g, 13.2 mmol) were placed in a 250 mL round bottom flask. 100 mL of ethanol was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch bed of silica gel. The silica bed was then washed twice with ethanol (2×50 mL) followed by hexane (2×50 mL). The product was then eluted through a plug of silica with dichloromethane. Most of the dichloromethane was removed under vacuum and the product was precipitated with 2-propanol, filtered, washed with hexane and dried to give 2.4 g of product (80.6% yield). EXAMPLES
[0288] Synthesis of compound 25
[0289] [ka]
[0290] Synthesis of 2-phenyl-5-(m-tolyl)pyridine. 2-Methylphenylboronic acid (5.1 g, 37.59 mmol), 2-phenyl-5-bromopyridine (8.0 g, 34.17 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (561 mg, 1.366 mmol), tripotassium phosphate (23.50 g, 102.51 mmol), 250 mL toluene and 25 mL water were placed in a 1 L round bottom flask. Nitrogen was bubbled directly into the mixture for 30 minutes before tris(dibenzylideneacetone)dipalladium(0) (312 mg, 0.341 mmol) was added. Nitrogen was then bubbled for an additional 15 minutes and the reaction mixture was heated to reflux under nitrogen for 16 hours. The mixture was cooled and the organic layer was separated from the aqueous layer. The organic layer was washed with saturated brine solution, dried over magnesium sulfate, filtered, and the solvent was removed under vacuum to give an off-white solid as crude product. The crude product was purified by column chromatography using silica gel as stationary phase and 2% ethyl acetate in hexane as mobile phase. 6.5 g of the desired product was obtained after purification (78% yield).
[0291] [ka]
[0292] Synthesis of Compound 25. Iridium triflate (from the synthesis of Compound 1) (3.25 g) and 2-phenyl-5-tolylpyridine (3.2 g) were placed in a 250 mL round bottom flask. A 50:50 mixture of methanol and ethanol (100 mL) was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×100 mL) followed by hexane (2×100 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as a mixture of compounds. The desired compounds were separated and isolated by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 0.53 g of the desired product was obtained after purification (15.6% yield). EXAMPLES
[0293] Synthesis of compound 26
[0294] [ka]
[0295] Synthesis of Compound 26. Iridium triflate (3.25 g) and 2-phenyl-5-tolylpyridine (3.2 g) were placed in a 250 mL round bottom flask. A 50:50 mixture of methanol and ethanol (100 mL) was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×100 mL) followed by hexane (2×100 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as the desired compound. The compound was further purified by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 3.38 g of the desired product was obtained after purification (100% yield). EXAMPLES
[0296] Synthesis of compound 27
[0297] [ka]
[0298] Synthesis of 2-phenyl-4-chloropyridine. 2,4-Dichloropyridine (10 g, 67.57 mmol), phenylboronic acid (9.0 g, 74.32 mmol), potassium carbonate (28 g, 202.70 mmol), 300 mL of dimethoxyethane and 30 mL of water were placed in a 1 L round bottom flask. Nitrogen was bubbled directly into the mixture for 30 minutes. Tetrakis(triphenylphosphine)palladium(0) (780 mg, 0.675 mmol) was added and nitrogen was bubbled into the reaction mixture for an additional 15 minutes. The reaction mixture was then heated to reflux under nitrogen for 16 hours. The reaction was then allowed to cool to room temperature and diluted with ethyl acetate and water. The organic and aqueous layers were separated and the aqueous layer was extracted with ethyl acetate. The organic layers were combined and washed with saturated brine solution. The organic layer was then dried over magnesium sulfate, filtered, and the solvent was removed under vacuum to give an off-white solid as crude product. The crude product was purified by column chromatography using silica gel as stationary phase and 2% ethyl acetate in hexane as mobile phase. 8.0 g of the desired product was obtained after purification (yield 54%). 11.5 g of the desired product was obtained after purification (yield 89.77%).
[0299] [ka]
[0300] Synthesis of 2-phenyl-4-(m-tolyl)pyridine. 2-Methylphenylboronic acid (6.3 g, 46.40 mmol), 2-phenyl-4-chloropyridine (8.0 g, 42.18 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (692 mg, 1.68 mmol), tripotassium phosphate (29.10 g, 126.54 mmol), 250 mL toluene and 25 mL water were placed in a 500 mL round bottom flask. Nitrogen was bubbled directly into the mixture for 30 minutes before adding tris(dibenzylideneacetone)dipalladium(0) (386 mg, 0.421 mmol). Nitrogen was then bubbled for an additional 15 minutes and the reaction mixture was then heated to reflux under nitrogen for 16 hours. The mixture was cooled and the organic layer was separated from the aqueous layer. The organic layer was washed with saturated brine solution, dried over magnesium sulfate, filtered, and the solvent was removed under vacuum to give an off-white solid as crude product. The crude product was purified by column chromatography using silica gel as stationary phase and 2% ethyl acetate in hexane as mobile phase. 8.0 g of the desired product was obtained after purification (yield 77.4%).
[0301] [ka]
[0302] Synthesis of Compound 27. Iridium triflate (4.0 g) and 2-phenyl-4-o-tolylpyridine (4.0 g) were placed in a 250 mL round bottom flask. A 50:50 mixture of methanol and ethanol (100 mL) was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×100 mL) followed by hexane (2×100 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as a mixture of compounds. The desired compounds were separated and isolated by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 2.0 g of the desired product was obtained after purification (48% yield). EXAMPLES
[0303] Synthesis of compound 28
[0304] [ka]
[0305] Synthesis of Compound 28. Iridium triflate (4.0 g) and 2-phenyl-4-o-tolylpyridine (4.0 g) were placed in a 250 mL round bottom flask. A 50:50 mixture of methanol and ethanol (100 mL) was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×100 mL) followed by hexane (2×100 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as the desired compound. The compound was further purified by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 3.6 g of the desired product was obtained after purification (86.6% yield). EXAMPLES
[0306] Synthesis of compound 29
[0307] [ka]
[0308] Synthesis of Compound 29. Iridium triflate (4.0 g, 4.62 mmol) and 2-phenylpyridine (2.15 g, 13.87 mmol) were placed in a 100 mL round bottom flask. A 50:50 mixture of methanol and ethanol (60 mL) was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×50 mL) followed by hexane (2×50 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as a mixture of compounds. The desired compounds were separated and isolated by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 1.1 g of the desired product was obtained after purification (31.6% yield). EXAMPLES
[0309] Synthesis of compound 30
[0310] [ka]
[0311] Synthesis of Compound 30. Iridium triflate (3.2 g) and 2,5-diphenyl-4-ethylpyridine (3.2 g) were placed in a 250 mL round bottom flask. 50 mL of ethanol was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2-inch silica gel bed. The silica bed was then washed twice with ethanol (2×50 mL) followed by hexane (2×50 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as a mixture of compounds. The desired compounds were separated and isolated by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 1.22 g of the desired product was obtained after purification (31.6% yield). EXAMPLES
[0312] Synthesis of compound 31
[0313] [ka]
[0314] Synthesis of 2-phenyl-5-methylpyridine. 2-Bromo-5-methylpyridine (11.25 g, 65.39 mmol), phenylboronic acid (9.5 g, 78.47 mmol), 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (1.0 g, 2.61 mmol), tripotassium phosphate (45 g, 196.17 mmol), toluene 250 mL, and water 25 mL were placed in a 500 mL round bottom flask. Nitrogen was bubbled directly into the mixture for 30 minutes, after which tris(dibenzylideneacetone)dipalladium(0) (598 mg, 0.653 mmol) was added. Nitrogen was bubbled for an additional 15 minutes, and then the reaction mixture was heated to reflux under nitrogen for 16 hours. The mixture was cooled and the organic layer was separated from the aqueous layer. The organic layer was washed with saturated brine solution, dried over magnesium sulfate, filtered, and the solvent was removed under vacuum to give an off-white solid as crude product. The crude product was purified by column chromatography using silica gel as stationary phase and 5%-10% ethyl acetate in hexane as mobile phase. 10.11 g of the desired product was obtained after purification (yield 92%).
[0315] [ka]
[0316] Synthesis of Ir dimer. 2-Phenyl-5-methylpyridine (10.11 g, 59.8 mmol) and IrCl3·3H2O (6.0 g, 17 mmol) were dissolved in 90 mL of 2-ethoxyethanol and 30 mL of water in a 250 mL round bottom flask. The reaction mixture was refluxed under nitrogen for 16 h. The reaction mixture was then cooled to room temperature and the precipitate was filtered and washed with methanol and then hexane. The iridium dimer was then dried under vacuum and used for the next step without further purification. 8.75 g of dimer was obtained after vacuum drying (yield 91.0%).
[0317] [ka]
[0318] Synthesis of Ir triflate. Iridium dimer (8.74 g, 7.75 mmol) was dissolved in 1.0 L of dichloromethane. Silver triflate (4.18 g, 16.27 mmol) was dissolved in 500 mL of methanol and added to the iridium dimer solution. The resulting mixture was stirred for 18 hours. The solution was then poured through a plug of Celite to remove silver chloride, and the solvent was evaporated to give 4.0 g of iridium triflate. The solid was used for the next step without further purification.
[0319] [ka]
[0320] Synthesis of Compound 31. Iridium triflate (4.0 g) and 2,5-diphenyl-4-methylpyridine (4.0 g) were placed in a 250 mL round bottom flask. A 50:50 mixture of methanol and ethanol (80 mL) was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×100 mL) followed by hexane (2×100 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as a mixture of compounds. The desired compounds were separated and isolated by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 3.75 g of the desired product was obtained after purification (90% yield). EXAMPLES
[0321] Synthesis of compound 32
[0322] [ka]
[0323] Synthesis of Compound 32. Iridium triflate (2.6 g, 3.66 mmol) and 2,5-ditolyl-4-methylpyridine (3.0 g, 11 mmol) were placed in a 100 mL round bottom flask. A 50:50 mixture of methanol and ethanol (50 mL) was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×100 mL) followed by hexane (2×100 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as a mixture of compounds. The desired compounds were separated and isolated by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 0.9 g of the desired product was obtained after purification (31.8% yield). EXAMPLES
[0324] Synthesis of compound 33
[0325] [ka]
[0326] Synthesis of Compound 33. Iridium triflate (2.8 g) and 2-phenylpyridine (2.8 g) were placed in a 250 mL round bottom flask. A 50:50 mixture of methanol and ethanol (80 mL) was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2 x 100 mL) followed by hexane (2 x 100 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as the desired compound. The compound was further purified by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 2.3 g of the desired product was obtained after purification (73.2% yield). EXAMPLES
[0327] Synthesis of compound 34
[0328] [ka]
[0329] Synthesis of Compound 34. Iridium triflate (3.5 g) and 2-phenyl-5-methylpyridine (3.5 g) were placed in a 250 mL round bottom flask. A 50:50 mixture of methanol and ethanol (80 mL) was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×100 mL) followed by hexane (2×100 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the crude product as a mixture of compounds. The desired compounds were separated and isolated by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 1.25 g of the desired product was obtained after purification (31.4% yield). EXAMPLES
[0330] Synthesis of compound 35
[0331] [ka]
[0332] Synthesis of compound 35. 2-Phenyl-5-o-tolylpyridine (8.8 g, 35.9 mmol, 6 eq.) and iridium trisacetylacetonate (2.93 g, 5.98 mmol, 1 eq.) were placed in a 50 mL round bottom flask. The flask was purged with nitrogen for 0.5 h. The reaction mixture was then heated to 230° C. in a sand bath for 48 h. The reaction mixture was allowed to cool to room temperature and 100 mL of dichloromethane was added. The mixture was filtered through a plug of silica gel. The solvent was removed under vacuum to obtain the crude product. The crude product was purified by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 0.4 g of the desired product was obtained after purification (7.2% yield). EXAMPLES
[0333] Synthesis of compound 36
[0334] [ka]
[0335] Synthesis of Compound 36. Iridium triflate and 3 molar equivalents of 2-phenylpyridine can be dissolved in a 50:50 mixture of methanol and ethanol, and the mixture was refluxed for 16 hours. The mixture can be purified using a method similar to that described in Example 30. EXAMPLES
[0336] Synthesis of compound 37
[0337] [ka]
[0338] Synthesis of Compound 37. Iridium triflate (2.45 g) and 2,5-diphenyl-4-ethylpyridine (2.58 g) were placed in a 250 mL round bottom flask. 50 mL of ethanol was added and the mixture was refluxed for 16 hours. Celite was added to the cooled solution and the mixture was poured onto a 2 inch silica gel bed. The silica bed was then washed twice with ethanol (2×50 mL) followed by hexane (2×50 mL). The product was then eluted through a plug of silica with dichloromethane. The dichloromethane was removed under vacuum to give the desired compound. The compound was further purified by column chromatography using silica gel as the stationary phase and 1:1 dichloromethane / hexane as the mobile phase. 1.25 g of the desired product was obtained after purification (48% yield).
[0339] (Device Example) All device examples were performed in high vacuum (<10 -7 The devices were assembled by thermal evaporation at 3700 Å (2200 Å) at 4000 Å. The anode electrode was 1200 Å of indium tin oxide (ITO). The cathode consisted of 10 Å of LiF, followed by 1000 Å of Al. Immediately after assembly, all devices were encapsulated in a nitrogen glove box (<1 ppm H20 and O2) with a glass lid sealed with epoxy resin, and a moisture getter was incorporated into the package.
[0340] The organic stack of device examples 1 and 2 in Table 2 consists of, from the ITO surface, 100 Å of E1 as a hole injection layer (HIL), 300 Å of 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (α-NPD) as a hole transport layer (HTL), 300 Å of H1 doped with 7% or 10% of Compound 1 as an emission layer (EML), 50 Å of H1 as a blocking layer, and 400 Å of Alq3 (tris-8-hydroxyquinoline aluminum) as an ETL. The device structures of the device examples are also summarized in Figure 3.
[0341] Comparative Examples 1 and 2 were constructed in the same manner as Device Example, except that E1 was used as the emissive dopant.
[0342] The device structures and data are summarized in Tables 2 and 3. Table 2 shows the device structures and Table 3 shows the corresponding measurement results for these devices. As used herein, E1, H1 and NPD have the following structures: [ka] has.
[0343] [Table 2]
[0344] [Table 3]
[0345] From the device examples in Table 3, it can be seen that devices containing the compounds of the present invention have particularly good properties, especially devices having an emissive layer containing Compound 1 as the emissive dopant. These devices demonstrate that Compound 1 is beneficial to device stability. In particular, Comparative Example 1 and Device Example 1 exhibited excellent device stability at RT 760 and 900 hours, respectively. 80% (defined as the time it takes for the initial luminance L0 to drop to 80% of its initial luminance). Comparative Example 2 and Device Example 2 have RTs of 1130 and 1400 hours, respectively. 80% These results indicate that the extended conjugation of the heteroleptic Ir(III) complexes is beneficial for device stability.
[0346] A low evaporation temperature is desirable for the manufacture of OLEDs. Materials with low evaporation temperatures have less thermal stress and require prolonged heating of the material during the manufacture of OLEDs, resulting in cleaner evaporation. The extended conjugation achieved by adding a phenyl to the heteroatom ring of compound 1 results in a lower sublimation temperature. Thus, devices containing compound 1 result in improved manufacturing.
[0347] The organic stacks of device examples 3-12 in Table 4 consist of, from the ITO surface, 100 Å of E1 as a hole injection layer (HIL), 300 Å of 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (α-NPD) as a hole transport layer (HTL), 300 Å of H1 or H2 doped with 7%, 10% or 15% of the compound of the present invention as an emission layer (EML), 50 Å of H1 or H2 as a blocking layer, and 400 Å of Alq3 (tris-8-hydroxyquinoline aluminum) as an ETL. The device structures of the device examples are also summarized in FIG. 3.
[0348] Comparative Example 3 was constructed in the same manner as Device Example 3, except that E1 was used as the emissive dopant.
[0349] The device structures and data are summarized in Tables 4 and 5. Table 4 shows the device structures and Table 5 shows the corresponding measurement results for these devices. As used herein, E1, H1, H2 and NPD have the following structures: [ka] has.
[0350] [Table 4A]
[0351] [Table 4B]
[0352] [Table 5]
[0353] From the device examples in Table 4, it can be seen that the devices containing the compounds of the present invention have particularly good properties. In particular, the devices having an emissive layer containing Compound 1, Compound 2, and Compounds 8 to 12 as emissive dopants show that the compounds of the present invention are beneficial to device stability.
[0354] A specific device is provided in which the compounds of the present invention, Compounds 21 to 35, are the emissive dopants and H-2 is the host. The organic stack of Device Examples 21 to 35 consists of, from the ITO surface, 100 Å of E1 as a hole injection layer (HIL), 300 Å of 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (α-NPD) as a hole transport layer (HTL), 300 Å of H2 doped with 7% of Compounds 21 to 35 and 37 as an emissive layer (EML), 100 Å of H2 as an electron transport layer (ETL2), and 400 Å of Alq3 (tris-8-hydroxyquinoline aluminum) as an electron transport layer (ETL1).
[0355] Device Comparative Examples 4 to 6 were fabricated in the same manner as Device Example, except that Device Comparative Example 4 used E2 as the emissive dopant, Device Comparative Example 5 used CBP as the host, E3 as the emissive dopant, 50 Å of HPT as the ETL2, and 450 Å of Alq3 as the ETL1, and Device Comparative Example 6 used E4 as the emissive dopant.
[0356] As used herein, the following compounds have the following structures: [ka] has.
[0357] Provided are specific materials for use in OLEDs. The materials can be used as emissive dopants in the emissive layer of such devices. The materials provided herein can be used to provide devices with high efficiency and narrow electroluminescence. In addition, these materials can have improved stability and processability, such as high solubility and low evaporation temperature.
[0358] [Table 6]
[0359] Table 6 shows the evaporation temperatures of the emissive compounds used in the device examples, compounds 21-33, compared to those of the emissive compounds E2 and E3 used in the device comparative examples 4 and 5, respectively. In particular, compounds 21-24 have significantly lower evaporation temperatures than E3. Lower evaporation temperatures are desirable properties for thermal evaporation and long-term thermal stability of the dopant. It is believed that the C-ring phenyl-pyridine of compounds 21-23 has more twists between the two rings than the phenyl-pyridine twist present in E3. Heteroleptic compounds with a twisted C-ring feature (compounds 25-33 and 37) have evaporation temperatures equal to or lower than E2, which does not have a C-ring at all. The results show that the twisted C-ring structure reduces the evaporation temperature but retains molecular weight equal to or higher than structurally similar compounds that do not have this structure.
[0360] [Table 7]
[0361] Table 7 shows additional device data for the device examples and comparative examples. In particular, Table 7 shows the λ for device examples 16-18 and 27 compared to device comparative examples 4, 5, and 6. maxand CIE coordinates are shown. The data shows that Device Examples 16-18 and 27 are significantly blue shifted from Device Comparative Example 5. This result suggests that the presence of the twisted phenyl C ring may reduce conjugation.
[0362] [Table 8]
[0363] Table 8 shows a comparison of device characteristics between device examples 16-29 and comparative examples 4 and 6. From this data, it can be seen that device examples 16 (compound 21), 17 (compound 22), 19 (compound 25), 20 (compound 26), 21 (compound 27), 23 (compound 29), 24 (compound 30), 25 (compound 31), 27 (compound 34), 28 (compound 25), 29 (compound 37) provide high efficiency and long device lifetime. In particular, device examples 16, 17, 19, 23, 24, 25, and 27, which use compounds 21, 22, 25, 29, 30, 31, and 34, respectively, as the emissive dopant, have very good device performance. These particular devices are comparable to the 196 hour RT of device comparative example 4. 80% Compared to RTs of 210, 260, 245, 237, 223, 254 and 290 hours 80% (Initial brightness L o(defined as the time required for L0 to drop from 100% to 80% at room temperature under constant DC driving) at room temperature. Furthermore, device examples 16, 17, 19, 23, 24, 25 and 27 all operate at a higher L0 than device comparative example 4. The results show that the phenyl C ring can improve device stability by adding some conjugation to the emissive dopant. However, the conjugation is limited by the presence of the twisted structure mentioned above, which causes less red shift in emission compared to phenyl in normal conjugation such as E-3. Furthermore, the EL spectra of device examples 16-20, 23-25 and 27-29 are all narrower than that of comparative example 4. Narrow emission is a desirable factor for achieving saturated color coordinates, LE:EQE conversion, microcavity tuning and color filter matching in OLED technology.
[0364] It should be understood that the various embodiments described herein are merely illustrative and do not limit the scope of the invention. For example, many of the materials and structures described herein can be substituted with other materials and structures without departing from the spirit of the invention. Thus, the invention as claimed can include modifications of the specific examples and preferred embodiments described herein, as would be apparent to one of ordinary skill in the art. It should be understood that the various theories as to why the invention works are not intended to be limiting. [Explanation of symbols]
[0365] 100 devices 110 Substrate 115 Anode 120 Hole injection layer 125 Hole transport layer 130 Electron blocking layer 135 Light-emitting layer 140 Hole blocking layer 145 Electron transport layer 150 Electron injection layer 155 Protective layer 160 Cathode 162 First conductive layer 164 Second conductive layer
Claims
1. anode: Cathode; and An organic layer disposed between the anode and the cathode 1. An organic light emitting device comprising: 【Chemistry 1】 (wherein B and C are each independently a 5- or 6-membered carbocyclic or heterocyclic ring; AB is a nitrogen atom of ring A and a sp 2 represents a bond pair of a carbocyclic or heterocyclic ring coordinated to a metal M through a hybrid atom, AC represents a bond pair of carbocyclic or heterocyclic rings; R a , R b and R C can represent mono-, di-, tri- or tetra-substitution; R a , R b and R C are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, aralkyl, aryl, and heteroaryl; X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 , X 8 and X 9 are independently selected from carbon and nitrogen; R 1 and R 2 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, aralkyl, aryl, and heteroaryl; R 1 , R 2 , and R adjacent to C a At least one of the substituents is not hydrogen; The ligand L is coordinated to a metal M having an atomic number greater than 40. The device further comprises a compound comprising a ligand L having the formula:
2. The device of claim 1 , wherein A is pyridine.
3. R 1 , R 2 and R a The device of claim 1 , wherein only one of the substituents is not hydrogen.
4. R 1 , R 2 and R a The device of claim 1 , wherein only one of the substituents is alkyl.
5. R 1 , R 2 and R a The device of claim 1 , wherein only one of the substituents is ethyl.
6. R 1 , R 2 and R a The device of claim 1 , wherein only one of the substituents is methyl.
7. The compound has the following structure: 【Chemistry 2】 (wherein m is the oxidation state of the metal M; n is at least 1, L' is a monoanionic bidentate ligand. The device of claim 1 , comprising:
8. The device of claim 7 wherein the metal M is Ir.
9. The device of claim 7 , wherein A is pyridine.
10. R 1 , R 2 , and R adjacent to C a The device of claim 7 , wherein only one of the substituents is not hydrogen.
11. R 1 , R 2 , and R adjacent to C a The device of claim 7 , wherein only one of the substituents is alkyl.
12. R 1 , R 2 , and R adjacent to C a The device of claim 7 , wherein only one of the substituents is ethyl.
13. R 1 , R 2 , and R adjacent to C a The device of claim 7 , wherein only one of the substituents is methyl.
14. The compound is 【Chemistry 3】 (In the formula, R 1 , R 2 , R 3 and R 4 At least one of the is not hydrogen, R 5 is selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, aralkyl, aryl, and heteroaryl. The device of claim 1 , selected from the group consisting of:
Citation Information
Patent Citations
Organic electroluminescent element
JP2001357977A
Organic electroluminescent element, illumination device, and display device
JP2004355898A
Organometallic complex, and light emitting element, light emitting device and electronics using the complex
JP2007284432A
Solution-processed organometallic complexes and use of solution-processed organometallic complexes in electroluminescent devices
JP2008531684A
Material for organic electroluminescence element, organic electroluminescence element, display device and illumination device
WO2005083033A1
